Genetics of dementia: Update and guidelines for the clinician
With increased frequency, clinical geneticists are asked for genetic advice on the heredity of dementia in families. Alzheimer's disease is in most cases a complex disease, but may be autosomal dominant inherited. Mutations in the PSEN1 gene are the most common genetic cause of early onset Alzh...
Uložené v:
| Vydané v: | American journal of medical genetics. Part B, Neuropsychiatric genetics Ročník 159B; číslo 6; s. 628 - 643 |
|---|---|
| Hlavní autori: | , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.09.2012
Wiley-Liss Wiley Subscription Services, Inc |
| Predmet: | |
| ISSN: | 1552-4841, 1552-485X, 1552-485X |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | With increased frequency, clinical geneticists are asked for genetic advice on the heredity of dementia in families. Alzheimer's disease is in most cases a complex disease, but may be autosomal dominant inherited. Mutations in the PSEN1 gene are the most common genetic cause of early onset Alzheimer's disease, whereas APP and PSEN2 gene mutations are less frequent. Familial frontotemporal dementia may be associated with a mutation in the MAPT or GRN gene, or with a repeat expansion in the C9orf72 gene. All these genes show autosomal dominant inheritance with a high penetrance. Although Alzheimer's disease and frontotemporal dementia are clinically distinguishable entities, phenotypical overlap may occur. Rarely, dementia is caused by mutations in other autosomal dominant genes or by genetic defects with autosomal recessive, X‐linked dominant or mitochondrial inheritance. The inherited forms of frontotemporal dementia and Alzheimer's disease show a large phenotypic variability also within families, resulting in many remaining uncertainties for mutation carriers. Therefore, genetic counseling before performing genetic testing is essential in both symptomatic individuals and healthy at risk relatives. This review provides an overview of the genetic causes of dementia and discusses all aspects relevant for genetic counseling and testing. Furthermore, based on current knowledge, we provide algorithms for genetic testing in patients with early onset Alzheimer's disease or frontotemporal dementia. © 2012 Wiley Periodicals, Inc. |
|---|---|
| AbstractList | With increased frequency, clinical geneticists are asked for genetic advice on the heredity of dementia in families. Alzheimer's disease is in most cases a complex disease, but may be autosomal dominant inherited. Mutations in the PSEN1 gene are the most common genetic cause of early onset Alzheimer's disease, whereas APP and PSEN2 gene mutations are less frequent. Familial frontotemporal dementia may be associated with a mutation in the MAPT or GRN gene, or with a repeat expansion in the C9orf72 gene. All these genes show autosomal dominant inheritance with a high penetrance. Although Alzheimer's disease and frontotemporal dementia are clinically distinguishable entities, phenotypical overlap may occur. Rarely, dementia is caused by mutations in other autosomal dominant genes or by genetic defects with autosomal recessive, X-linked dominant or mitochondrial inheritance. The inherited forms of frontotemporal dementia and Alzheimer's disease show a large phenotypic variability also within families, resulting in many remaining uncertainties for mutation carriers. Therefore, genetic counseling before performing genetic testing is essential in both symptomatic individuals and healthy at risk relatives. This review provides an overview of the genetic causes of dementia and discusses all aspects relevant for genetic counseling and testing. Furthermore, based on current knowledge, we provide algorithms for genetic testing in patients with early onset Alzheimer's disease or frontotemporal dementia. With increased frequency, clinical geneticists are asked for genetic advice on the heredity of dementia in families. Alzheimer's disease is in most cases a complex disease, but may be autosomal dominant inherited. Mutations in the PSEN1 gene are the most common genetic cause of early onset Alzheimer's disease, whereas APP and PSEN2 gene mutations are less frequent. Familial frontotemporal dementia may be associated with a mutation in the MAPT or GRN gene, or with a repeat expansion in the C9orf72 gene. All these genes show autosomal dominant inheritance with a high penetrance. Although Alzheimer's disease and frontotemporal dementia are clinically distinguishable entities, phenotypical overlap may occur. Rarely, dementia is caused by mutations in other autosomal dominant genes or by genetic defects with autosomal recessive, X-linked dominant or mitochondrial inheritance. The inherited forms of frontotemporal dementia and Alzheimer's disease show a large phenotypic variability also within families, resulting in many remaining uncertainties for mutation carriers. Therefore, genetic counseling before performing genetic testing is essential in both symptomatic individuals and healthy at risk relatives. This review provides an overview of the genetic causes of dementia and discusses all aspects relevant for genetic counseling and testing. Furthermore, based on current knowledge, we provide algorithms for genetic testing in patients with early onset Alzheimer's disease or frontotemporal dementia.With increased frequency, clinical geneticists are asked for genetic advice on the heredity of dementia in families. Alzheimer's disease is in most cases a complex disease, but may be autosomal dominant inherited. Mutations in the PSEN1 gene are the most common genetic cause of early onset Alzheimer's disease, whereas APP and PSEN2 gene mutations are less frequent. Familial frontotemporal dementia may be associated with a mutation in the MAPT or GRN gene, or with a repeat expansion in the C9orf72 gene. All these genes show autosomal dominant inheritance with a high penetrance. Although Alzheimer's disease and frontotemporal dementia are clinically distinguishable entities, phenotypical overlap may occur. Rarely, dementia is caused by mutations in other autosomal dominant genes or by genetic defects with autosomal recessive, X-linked dominant or mitochondrial inheritance. The inherited forms of frontotemporal dementia and Alzheimer's disease show a large phenotypic variability also within families, resulting in many remaining uncertainties for mutation carriers. Therefore, genetic counseling before performing genetic testing is essential in both symptomatic individuals and healthy at risk relatives. This review provides an overview of the genetic causes of dementia and discusses all aspects relevant for genetic counseling and testing. Furthermore, based on current knowledge, we provide algorithms for genetic testing in patients with early onset Alzheimer's disease or frontotemporal dementia. With increased frequency, clinical geneticists are asked for genetic advice on the heredity of dementia in families. Alzheimer's disease is in most cases a complex disease, but may be autosomal dominant inherited. Mutations in the PSEN1 gene are the most common genetic cause of early onset Alzheimer's disease, whereas APP and PSEN2 gene mutations are less frequent. Familial frontotemporal dementia may be associated with a mutation in the MAPT or GRN gene, or with a repeat expansion in the C9orf72 gene. All these genes show autosomal dominant inheritance with a high penetrance. Although Alzheimer's disease and frontotemporal dementia are clinically distinguishable entities, phenotypical overlap may occur. Rarely, dementia is caused by mutations in other autosomal dominant genes or by genetic defects with autosomal recessive, X‐linked dominant or mitochondrial inheritance. The inherited forms of frontotemporal dementia and Alzheimer's disease show a large phenotypic variability also within families, resulting in many remaining uncertainties for mutation carriers. Therefore, genetic counseling before performing genetic testing is essential in both symptomatic individuals and healthy at risk relatives. This review provides an overview of the genetic causes of dementia and discusses all aspects relevant for genetic counseling and testing. Furthermore, based on current knowledge, we provide algorithms for genetic testing in patients with early onset Alzheimer's disease or frontotemporal dementia. © 2012 Wiley Periodicals, Inc. With increased frequency, clinical geneticists are asked for genetic advice on the heredity of dementia in families. Alzheimer's disease is in most cases a complex disease, but may be autosomal dominant inherited. Mutations in the PSEN1 gene are the most common genetic cause of early onset Alzheimer's disease, whereas APP and PSEN2 gene mutations are less frequent. Familial frontotemporal dementia may be associated with a mutation in the MAPT or GRN gene, or with a repeat expansion in the C9orf72 gene. All these genes show autosomal dominant inheritance with a high penetrance. Although Alzheimer's disease and frontotemporal dementia are clinically distinguishable entities, phenotypical overlap may occur. Rarely, dementia is caused by mutations in other autosomal dominant genes or by genetic defects with autosomal recessive, X-linked dominant or mitochondrial inheritance. The inherited forms of frontotemporal dementia and Alzheimer's disease show a large phenotypic variability also within families, resulting in many remaining uncertainties for mutation carriers. Therefore, genetic counseling before performing genetic testing is essential in both symptomatic individuals and healthy at risk relatives. This review provides an overview of the genetic causes of dementia and discusses all aspects relevant for genetic counseling and testing. Furthermore, based on current knowledge, we provide algorithms for genetic testing in patients with early onset Alzheimer's disease or frontotemporal dementia. © 2012 Wiley Periodicals, Inc. [PUBLICATION ABSTRACT] With increased frequency, clinical geneticists are asked for genetic advice on the heredity of dementia in families. Alzheimer's disease is in most cases a complex disease, but may be autosomal dominant inherited. Mutations in the PSEN1 gene are the most common genetic cause of early onset Alzheimer's disease, whereas APP and PSEN2 gene mutations are less frequent. Familial frontotemporal dementia may be associated with a mutation in the MAPT or GRN gene, or with a repeat expansion in the C9orf72 gene. All these genes show autosomal dominant inheritance with a high penetrance. Although Alzheimer's disease and frontotemporal dementia are clinically distinguishable entities, phenotypical overlap may occur. Rarely, dementia is caused by mutations in other autosomal dominant genes or by genetic defects with autosomal recessive, X-linked dominant or mitochondrial inheritance. The inherited forms of frontotemporal dementia and Alzheimer's disease show a large phenotypic variability also within families, resulting in many remaining uncertainties for mutation carriers. Therefore, genetic counseling before performing genetic testing is essential in both symptomatic individuals and healthy at risk relatives. This review provides an overview of the genetic causes of dementia and discusses all aspects relevant for genetic counseling and testing. Furthermore, based on current knowledge, we provide algorithms for genetic testing in patients with early onset Alzheimer's disease or frontotemporal dementia. copyright 2012 Wiley Periodicals, Inc. |
| Author | Pijnenburg, Yolande A.L. Elting, Mariet W. van Swieten, John C. Cohn-Hokke, Petra E. |
| Author_xml | – sequence: 1 givenname: Petra E. surname: Cohn-Hokke fullname: Cohn-Hokke, Petra E. email: p.cohn@vumc.nl organization: Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands – sequence: 2 givenname: Mariet W. surname: Elting fullname: Elting, Mariet W. organization: Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands – sequence: 3 givenname: Yolande A.L. surname: Pijnenburg fullname: Pijnenburg, Yolande A.L. organization: Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands – sequence: 4 givenname: John C. surname: van Swieten fullname: van Swieten, John C. organization: Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26275078$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22815225$$D View this record in MEDLINE/PubMed |
| BookMark | eNqF0d9rFDEQB_AgFftD33yWBRF8cM9Jstkfgg-l2tPS1h9Y9C3MZSc15272THbR_vem3l2FgvqUBD7fYSazz3b84ImxhxxmHEA8x2V_OVvMpIAa7rA9rpTIi1p92bm5F3yX7ce4BJCgquoe2xWi5koItcdezsnT6EzMBpu11JMfHb7ILlYtjpShb7PLybXUOU8xs0PIxq-UmfR0xqG_z-5a7CI92JwH7OL49aejN_npu_nbo8PT3CgJkJdWFlZYIxemsU1VIBZSKuDKoGm5sLKtlZFtgyAaqqVY1ADEeStrldosUB6wp-u6qzB8nyiOunfRUNehp2GKmheNKNM8wP9PQcpC8YqXiT6-RZfDFHwaJBUsUw8NFJDUo42aFj21ehVcj-FKb_8wgScbgNFgZwN64-IfV4pKQVUnJ9bOhCHGQFYbN-LoBj8GdF3qTF8vVF8vVC_074Wm0LNboW3dv3C55j9cR1f_tPrw5Gy-TeXrlIsj_bxJYfimy0pWSn8-n-uT9-XH41cfzvWZ_AXQkL28 |
| CitedBy_id | crossref_primary_10_1016_j_ajp_2022_103094 crossref_primary_10_1212_WNL_0b013e3182a8250c crossref_primary_10_1007_s00415_014_7456_y crossref_primary_10_1016_j_pec_2017_07_013 crossref_primary_10_1212_WNL_0000000000008387 crossref_primary_10_1080_21678421_2017_1332079 crossref_primary_10_1146_annurev_clinpsy_032813_153653 crossref_primary_10_1007_s11011_013_9412_4 crossref_primary_10_1002_dad2_12471 crossref_primary_10_1155_2014_291862 crossref_primary_10_3389_fnbeh_2015_00299 crossref_primary_10_1038_s41598_020_76794_9 crossref_primary_10_1016_S0140_6736_13_60630_3 crossref_primary_10_1093_brain_awab028 crossref_primary_10_1186_alzrt197 crossref_primary_10_1007_s11910_013_0366_z crossref_primary_10_1016_j_neurobiolaging_2014_01_023 crossref_primary_10_1212_WNL_0000000000210273 crossref_primary_10_1097_WAD_0000000000000458 crossref_primary_10_1136_jnnp_2013_306285 crossref_primary_10_1016_j_neurobiolaging_2018_02_006 crossref_primary_10_1016_j_nbd_2020_104946 crossref_primary_10_1371_journal_pone_0076409 crossref_primary_10_1080_21678421_2019_1588904 crossref_primary_10_1371_journal_pone_0071750 |
| Cites_doi | 10.1212/01.wnl.0000171397.32851.bc 10.1093/brain/awr195 10.1093/brain/awh356 10.1097/GIM.0b013e318164e4cf 10.1093/brain/awl226 10.1192/bjp.bp.109.068981 10.1038/nature10353 10.1212/WNL.34.7.939 10.1212/WNL.47.5.1113 10.1212/WNL.58.11.1615 10.1038/ng.440 10.1111/j.1468-1331.2007.01664.x 10.1002/ana.10267 10.1016/j.neurobiolaging.2007.05.022 10.1016/j.jns.2009.07.011 10.1126/science.1566067 10.1016/j.jalz.2011.03.005 10.1001/archneurol.2009.285 10.3233/JAD-2010-1337 10.1016/j.expneurol.2007.08.016 10.1177/0891988705281883 10.1212/WNL.0b013e3181bf997a 10.1074/jbc.M705115200 10.1001/archneurol.2009.328 10.1093/brain/awl271 10.1038/ng.439 10.1080/13554790903456209 10.1097/WAD.0b013e3181eff860 10.3233/JAD-2010-100837 10.1212/WNL.51.6.1546 10.1136/jnnp.74.9.1206 10.1007/s00415-002-0896-9 10.1001/archneur.62.7.1091 10.1001/archneur.58.11.1803 10.1001/archneurol.2010.201 10.1093/hmg/ddm309 10.1001/archneurol.2011.53 10.1097/WAD.0b013e31819e6b28 10.1007/s00415-005-0019-5 10.1126/science.1199214 10.1002/ana.20366 10.1093/brain/awl212 10.1007/s10897-009-9222-3 10.1161/STROKEAHA.108.542308 10.1001/jama.287.3.329 10.3233/JAD-2010-101032 10.1111/j.1750-3639.2007.00052.x 10.1016/j.jalz.2011.02.004 10.1212/WNL.0b013e3181ccc732 10.1038/nature05017 10.1016/j.neurobiolaging.2009.08.016 10.1038/sj.ejhg.5201966 10.1016/S1474-4422(10)70299-4 10.1093/brain/awr355 10.1212/01.wnl.0000343851.46573.67 10.7326/0003-4819-601 10.1371/journal.pone.0009872 10.1038/ng1609 10.1002/mds.22697 10.1038/nature05016 10.1073/pnas.95.13.7737 10.1016/j.neurobiolaging.2007.11.002 10.1212/WNL.56.suppl_4.S21 10.1002/1096-8628(20011001)103:2<138::AID-AJMG1529>3.0.CO;2-8 10.1212/01.wnl.0000172911.39167.b6 10.1038/ng1718 10.1093/brain/awl203 10.1002/ana.22264 10.1016/S1474-4422(10)70159-9 10.1038/mp.2011.52 10.1001/archneur.58.11.1828 10.1212/01.wnl.0000311445.21321.fc 10.1002/humu.9484 10.1111/j.1468-1331.2010.02985.x 10.1002/ana.10721 10.1212/WNL.44.9.1683 10.1093/brain/awp062 10.1016/S1474-4422(11)70261-7 10.1212/01.wnl.0000187068.92184.63 10.1002/ajmg.b.30410 10.1001/archneur.62.6.925 10.1093/hmg/7.1.43 10.1177/1533317506290448 10.1001/archneurol.2010.319 10.1002/ajmg.b.31099 10.1007/s00401-010-0698-6 10.1002/ana.20083 10.1016/S0304-3940(96)13138-4 10.1212/01.wnl.0000267642.41594.9d 10.1212/01.wnl.0000334277.16896.fa 10.1093/brain/awr216 10.1016/j.neurobiolaging.2011.08.005 10.1001/archneur.65.4.506 10.1093/brain/awn352 10.1186/1471-2377-8-48 10.1523/JNEUROSCI.4305-10.2010 10.1212/WNL.0b013e31821103e6 10.1038/349704a0 10.1097/NEN.0b013e3182270c54 10.1001/archneur.58.3.383 10.1038/ng1095-219 10.1177/1533317507302320 10.1136/jmg.2005.033456 10.1097/GIM.0b013e31821d69b8 10.1016/j.jns.2006.11.013 10.1093/hmg/ddl241 10.1002/ana.21099 10.1111/j.1468-1331.2008.02069.x 10.1001/archneur.57.1.72 10.1136/jnnp.2007.121137 10.1093/brain/awg204 10.1212/01.wnl.0000244749.20056.d4 10.1038/375754a0 10.1016/j.neuron.2011.09.011 10.1001/archneur.59.11.1759 10.1212/01.WNL.0000086811.39675.79 10.1007/s00415-009-5163-x 10.1016/j.neuron.2011.09.010 10.1126/science.1072994 10.1001/archneur.63.9.1307 10.1093/brain/awn012 10.1056/NEJMc1113592 10.1212/WNL.57.4.621 10.1212/01.wnl.0000319702.37497.72 10.1056/NEJMoa0809578 10.1002/1531-8249(20010201)49:2<263::AID-ANA50>3.0.CO;2-K 10.1002/mds.22642 10.1093/brain/awr179 10.1159/000077158 10.1523/JNEUROSCI.0730-07.2007 10.1093/brain/awr353 10.1136/jnnp.2006.113803 10.1086/302702 10.1038/31508 10.1007/s00401-011-0816-0 10.1007/s00401-009-0501-8 10.1002/humu.21100 10.1016/j.neuron.2010.11.036 10.3233/JAD-2004-6503 10.1016/S0197-4580(00)00202-5 10.1007/s12031-011-9557-8 10.1038/ng1332 10.1007/s00401-011-0907-y 10.1002/ana.1009 10.1212/01.wnl.0000325058.10218.fc 10.1007/s00259-008-0833-y 10.1093/brain/awm331 10.1007/s12031-011-9637-9 10.1093/brain/awq033 10.3988/jcn.2011.7.1.1 10.1001/archneurol.2010.113 10.1074/jbc.R800019200 10.1212/WNL.0b013e3181b389d9 10.1002/1531-8249(199908)46:2<243::AID-ANA14>3.0.CO;2-L 10.1002/humu.20520 10.1093/brain/awq216 10.1016/j.neurobiolaging.2011.10.014 10.1212/01.WNL.0000042088.22694.E3 10.1212/WNL.56.11.1545 10.1093/hmg/ddh134 10.1212/WNL.59.8.1134 10.1212/01.wnl.0000334278.11022.42 10.1007/s10897-005-4063-1 10.1093/brain/awp009 10.1007/s10048-008-0127-3 10.1086/302553 10.1006/exnr.2000.7613 10.1212/WNL.55.10.1577 10.1159/000058328 10.1136/jnnp.72.2.266 10.1001/archpsyc.63.2.168 10.1038/ng.801 10.1016/j.neuron.2008.11.007 10.1007/s00415-009-5404-z 10.1038/ng0892-345 10.1212/WNL.0b013e3181f07e0c 10.1177/0891988710383570 10.1017/S1462399409001136 10.1016/j.neulet.2007.03.044 10.1212/WNL.50.6.1541 |
| ContentType | Journal Article |
| Copyright | Copyright © 2012 Wiley Periodicals, Inc. 2015 INIST-CNRS |
| Copyright_xml | – notice: Copyright © 2012 Wiley Periodicals, Inc. – notice: 2015 INIST-CNRS |
| DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7TK 8FD FR3 K9. P64 RC3 7X8 |
| DOI | 10.1002/ajmg.b.32080 |
| DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Genetics Abstracts Engineering Research Database Technology Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef ProQuest Health & Medical Complete (Alumni) Genetics Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1552-485X |
| EndPage | 643 |
| ExternalDocumentID | 3156398151 22815225 26275078 10_1002_ajmg_b_32080 AJMG32080 ark_67375_WNG_JP6RFDQN_M |
| Genre | reviewArticle Journal Article Review |
| GroupedDBID | .55 .GA .Y3 05W 0R~ 10A 1L6 1OC 23M 31~ 33P 4.4 51W 51X 52N 52O 52P 52S 52T 52W 52X 53G 5GY 5VS 7PT 8-1 8-4 8-5 8UM AAEVG AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABIVO ABJNI ACAHQ ACBWZ ACCZN ACFBH ACGFO ACGFS ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADZMN AEIGN AEIMD AEUYR AEYWJ AFBPY AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGYGG AHBTC AIAGR AITYG AIURR ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN BDRZF BFHJK BRXPI BSCLL BY8 C45 CS3 D-F DCZOG DPXWK DR2 DRFUL DRSTM EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S GNP GODZA HBH HF~ HGLYW HHY HHZ HVGLF IX1 KQQ LATKE LAW LEEKS LH4 LOXES LP6 LP7 LUTES LYRES MEWTI MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM OIG OVD P2P P2W P4D QB0 QRW ROL SUPJJ SV3 TEORI UB1 V2E W99 WJL WQJ WXSBR X7M XG1 XV2 AAHHS ACCFJ ADZOD AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE AMBMR RWI WIH WRC AAYXX CITATION O8X IQODW CGR CUY CVF ECM EIF NPM 7TK 8FD FR3 K9. P64 RC3 7X8 |
| ID | FETCH-LOGICAL-c5300-6f34f2fc3bc9f974aa4335015cacd12f3d85c3d9a029e832b800e11d3851524a3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 32 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000308492000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1552-4841 1552-485X |
| IngestDate | Thu Jul 10 22:43:00 EDT 2025 Fri Jul 11 10:08:52 EDT 2025 Tue Nov 04 22:13:38 EST 2025 Mon Jul 21 06:01:59 EDT 2025 Wed Apr 02 07:21:01 EDT 2025 Sat Nov 29 08:03:18 EST 2025 Tue Nov 18 21:52:52 EST 2025 Wed Jan 22 16:48:15 EST 2025 Sun Sep 21 06:29:23 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Nervous system diseases Alzheimer disease early onset Recommendation Cerebral disorder Genetic counseling genetic testing Central nervous system disease Genetics Early Degenerative disease Frontotemporal dementia Alzheimer's disease |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 Copyright © 2012 Wiley Periodicals, Inc. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5300-6f34f2fc3bc9f974aa4335015cacd12f3d85c3d9a029e832b800e11d3851524a3 |
| Notes | ark:/67375/WNG-JP6RFDQN-M How to Cite this Article: Cohn-Hokke PE, Elting MW, Pijnenburg YAL, van Swieten JC. 2012. Genetics of Dementia: Update and Guidelines for the Clinician. Am J Med Genet Part B 159B:628-643. ArticleID:AJMG32080 istex:DCDC3317C05817D17461EF9EDA4D6DA20F31E465 How to Cite this Article: Cohn‐Hokke PE, Elting MW, Pijnenburg YAL, van Swieten JC. 2012. Genetics of Dementia: Update and Guidelines for the Clinician. Am J Med Genet Part B 159B:628–643. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| PMID | 22815225 |
| PQID | 1468009040 |
| PQPubID | 2028749 |
| PageCount | 16 |
| ParticipantIDs | proquest_miscellaneous_1492622501 proquest_miscellaneous_1033451716 proquest_journals_1468009040 pubmed_primary_22815225 pascalfrancis_primary_26275078 crossref_citationtrail_10_1002_ajmg_b_32080 crossref_primary_10_1002_ajmg_b_32080 wiley_primary_10_1002_ajmg_b_32080_AJMG32080 istex_primary_ark_67375_WNG_JP6RFDQN_M |
| PublicationCentury | 2000 |
| PublicationDate | September 2012 |
| PublicationDateYYYYMMDD | 2012-09-01 |
| PublicationDate_xml | – month: 09 year: 2012 text: September 2012 |
| PublicationDecade | 2010 |
| PublicationPlace | Hoboken |
| PublicationPlace_xml | – name: Hoboken – name: Hoboken, NJ – name: United States |
| PublicationTitle | American journal of medical genetics. Part B, Neuropsychiatric genetics |
| PublicationTitleAlternate | Am. J. Med. Genet |
| PublicationYear | 2012 |
| Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley-Liss Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley-Liss – name: Wiley Subscription Services, Inc |
| References | Halliday GM, Song YJ, Lepar G, Brooks WS, Kwok JB, Kersaitis C, Gregory G, Shepherd CE, Rahimi F, Schofield PR, Kril JJ. 2005. Pick bodies in a family with presenilin-1 Alzheimer's disease. Ann Neurol 57: 139-143. Herve D, Chabriat H. 2010. CADASIL. J Geriatr Psychiatry Neurol 23: 269-276. Deng H, Chen W, Hong S, Boycott K, Gorrie G, Siddique N, Yang Y, Fecto F, Shi y, Zhai H, Jiang H, Hirano M, Rampersaud E, Jansen G, Donkervoort S, Bigio E, Brooks B, Ajroud K, Sufit R, Haines J, Mugnaini E, Pericak-Vance M, Siddique T. 2011. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477: 211-215. Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J, Bettens K, Van Cauwenberghe C, Pereson S, Engelborghs S, Sieben A, De Jonghe P, Vandenberghe R, Santens P, De Bleecker J, Maes G, Baumer V, Dillen L, Joris G, Cuijt I, Corsmit E, Elinck E, Van Dongen J, Vermeulen S, Van den Broeck M, Vaerenberg C, Mattheijssens M, Peeters K, Robberecht W, Cras P, Martin JJ, De Deyn PP, Cruts M, Van Broeckhoven C. 2012. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: A gene identification study. Lancet Neurol 11: 54-65. Cannella M, Martino T, Simonelli M, Ciammola A, Gradini R, Ciarmiello A, Gianfrancesco F, Squitieri F. 2007. De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementia. J Neurol Neurosurg Psychiatry 78: 1411-1413. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH. 1996. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47: 1113-1124. Revesz T, Holton JL, Lashley T, Plant G, Frangione B, Rostagno A, Ghiso J. 2009. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 118: 115-130. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Holtta-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chio A, Restagno G, Borghero G, Sabatelli M, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ. 2011. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257-268. Devi G, Ottman R, Tang MX, Marder K, Stern Y, Mayeux R. 2000. Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan. Arch Neurol 57: 72-77. Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, Gass J, Cannon A, Rademakers R, Hutton M, Feldman HH. 2006. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 129: 3081-3090. Peters N, Opherk C, Bergmann T, Castro M, Herzog J, Dichgans M. 2005. Spectrum of mutations in biopsy-proven CADASIL: Implications for diagnostic strategies. Arch Neurol 62: 1091-1094. Queralt R, Ezquerra M, Lleo A, Castellvi M, Gelpi J, Ferrer I, Acarin N, Pasarin L, Blesa R, Oliva R. 2002. A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances. J Neurol Neurosurg Psychiatry 72: 266-269. Schofield EC, Halliday GM, Kwok J, Loy C, Double KL, Hodges JR. 2010. Low serum progranulin predicts the presence of mutations: A prospective study. J Alzheimers Dis 22: 981-984. Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R, Bisceglio G, Rovelet-Lecrux A, Boeve B, Petersen RC, Dickson DW, Younkin SG, Deramecourt V, Crook J, Graff-Radford NR, Rademakers R. 2009. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132: 583-591. Meeus B, Verstraeten A, Crosiers D, Engelborghs S, Van den Broeck M, Mattheijssens M, Peeters K, Corsmit E, Elinck E, Pickut B, Vandenberghe R, Cras P, De Deyn P, Van Broeckhoven C, Theuns J. 2012. DLB and PDD: A role for mutations in dementia and Parkinson disease genes? Neurobiol Aging 33: 629. Piguet O, Hornberger M, Mioshi E, Hodges JR. 2011. Behavioural-variant frontotemporal dementia: Diagnosis, clinical staging, and management. Lancet Neurol 10: 162-172. Yan J, Deng HX, Siddique N, Fecto F, Chen W, Yang Y, Liu E, Donkervoort S, Zheng JG, Shi Y, Ahmeti KB, Brooks B, Engel WK, Siddique T. 2010. Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology 75: 807-814. Munoz DG, Ros R, Fatas M, Bermejo F, de Yebenes JG. 2007. Progressive nonfluent aphasia associated with a new mutation V363I in tau gene. Am J Alzheimers Dis Other Demen 22: 294-299. Cox LE, Ferraiuolo L, Goodall EF, Heath PR, Higginbottom A, Mortiboys H, Hollinger HC, Hartley JA, Brockington A, Burness CE, Morrison KE, Wharton SB, Grierson AJ, Ince PG, Kirby J, Shaw PJ. 2010. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS ONE 5: e9872. Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, Beck J, Isaacs AM, Authier A, Ferrari R, Fox NC, Mackenzie IR, Warren JD, de Silva R, Holton J, Revesz T, Hardy J, Mead S, Rossor MN. 2009. The heritability and genetics of frontotemporal lobar degeneration. Neurology 73: 1451-1456. Riedijk SR, Niermeijer MFN, Dooijes D, Tibben A. 2009. A decade of genetic counseling in frontotemporal dementia affected families: Few counseling requests and much familial opposition to testing. J Genet Couns 18: 350-356. Ostojic J, Elfgren C, Passant U, Nilsson K, Gustafson L, Lannfelt L, Froelich Fabre S. 2004. The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy. Dement Geriatr Cogn Disord 17: 298-2301. Rohrer JD, Warren JD, Omar R, Mead S, Beck J, Revesz T, Holton J, Stevens JM, Al-Sarraj S, Pickering-Brown SM, Hardy J, Fox NC, Collinge J, Warrington EK, Rossor MN. 2008. Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol 65: 506-513. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. 1998. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 95: 7737-7741. Ladogana A, Sanchez-Juan P, Mitrova E, Green A, Cuadrado-Corrales N, Sanchez-Valle R, Koscova S, Aguzzi A, Sklaviadis T, Kulczycki J, Gawinecka J, Saiz A, Calero M, van Duijn CM, Pocchiari M, Knight R, Zerr I. 2009. Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol 256: 1620-1628. Mok K, Traynor B, Schymick J, Tienari P, Laaksovirta H, Peuralinna T, Myllykangas L, Chio A, Shatunov A, Boeve B, Boxer A, Dejesus-Hernandez M, Mackenzie I, Waite A, Williams N, Morris H, Simon-Sanchez J, van Swieten J, Heutink P, Restagno G, Mora G, Morrison K, Shaw P, Rollinson P, Al-Chalabi A, Rademakers R, Pickering-Brown S, Orrell R, Nalls M, Hardy J. 2012. The chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging 209.e3-209.e8. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, de Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van BC, Alperovitch A, Lathrop M, Amouyel P. 2009. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099. Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ. 2007. Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study. Neurology 68: 501-508. Chen-Plotkin AS, Martinez-Lage M, Sleiman PMA, Hu W, Greene R, Wood EM, Bing S, Grossman M, Schellenberg GD, Hatanpaa KJ, Weiner MF, White CL, Brooks WS, Halliday GM, Kril JJ, Gearing M, Beach TG, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Pickering-Brown SM, Snowden J, van Swieten JC, Heutink P, Seelaar H, Murrell JR, Ghetti B, Spina S, Grafman J, Kaye JA, Woltjer RL, Mesulam M, Bigio E, Llado A, Miller BL, Alzualde A, Moreno F, Rohrer JD, Mackenzie IRA, Feldman HH, Hamilton RL, Cruts M, Engelborghs S, de Deyn PP, Van Broeckhoven C, Bird TD, Cairns NJ, Goate A, Frosch MP, Riederer PF, Bogdanovic N, Lee VMY, Trojanowski JQ, Van Deerlin VM. 2011. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol 68: 488-497. Clark RF, Hutton M, Fuldner M, Froelich S, Karran E, Talbot C, Crook R, Lendon C, Prihar G, He C, Korenblat K, Martinez A, Wragg W, Busfield F, Behrens MI, Myers A, Norton J, Morris J, Mehta N, Pearson C, Lincoln S, Baker M, Duff K, Zehr C, Perez-Tur J, Houlden H, Ruiz A, Ossa J, Lopera F, Acros M, Madrigal L, Collinge J, Humphreys 2011; 477 2002; 14 2010; 16 2012; 366 2010; 19 2010; 17 2006; 38 1999; 46 2005; 62 2004; 6 2005; 65 2008; 35 2001; 49 1995; 375 2009; 118 1991; 115 2007; 78 2012; 11 1998; 393 2003; 54 2010; 23 2010; 22 2009; 11 2012; 135 2006; 21 2004; 36 2011; 70 2011; 72 2010; 197 2011; 68 2007; 61 2009; 361 2011; 69 1991; 349 2001; 56 1998; 95 2010; 5 2001; 57 2001; 58 1992; 1 2006; 442 2007; 68 2010; 30 2007; 69 2011; 122 2009; 18 2010; 9 2007; 17 2009; 66 2001; 168 2002; 72 2000; 66 2011; 76 2001; 22 2007; 208 2012; 33 2011; 134 2007; 14 2011; 7 2006; 141B 2004; 55 2001; 157 2009; 73 2009; 72 1992; 256 1984; 34 2005; 128 2002; 249 1998; 7 2008; 131 2005; 18 2005; 14 2002; 58 2002; 59 2009; 41 2009; 40 2002; 52 2010; 153B 2008; 9 2006; 253 2008; 8 2011; 10 2011; 13 2011; 16 2008; 70 2008; 71 2001; 103 2010; 67 2007; 28 2006; 63 2010; 68 2000; 57 2000; 55 2007; 252 2009; 287 2008; 65 1998; 50 2011; 25 2007; 419 2003; 126 2005; 37 1998; 51 2006; 129 2007; 22 2008; 60 1996; 218 2010; 74 2007; 27 2009; 23 2009; 24 2010; 75 2012 2002; 297 2008; 16 1995; 11 2006; 15 2008; 17 2009; 132 1994; 44 2008; 15 2005; 42 1999; 65 2009; 256 2011; 32 2010; 120 2008; 10 2003; 74 2011; 332 2008; 283 2009; 30 2004; 17 2010; 257 2002; 287 2004; 13 2010; 133 2011; 43 2011; 45 2003; 60 1996; 47 2003; 61 2005; 57 e_1_2_13_120_1 e_1_2_13_143_1 e_1_2_13_166_1 e_1_2_13_24_1 e_1_2_13_47_1 e_1_2_13_185_1 e_1_2_13_66_1 e_1_2_13_101_1 e_1_2_13_147_1 e_1_2_13_43_1 e_1_2_13_124_1 e_1_2_13_85_1 e_1_2_13_181_1 e_1_2_13_8_1 e_1_2_13_62_1 e_1_2_13_81_1 e_1_2_13_162_1 e_1_2_13_92_1 e_1_2_13_96_1 e_1_2_13_117_1 e_1_2_13_17_1 e_1_2_13_13_1 e_1_2_13_36_1 e_1_2_13_59_1 e_1_2_13_154_1 e_1_2_13_131_1 e_1_2_13_32_1 e_1_2_13_55_1 e_1_2_13_78_1 e_1_2_13_112_1 e_1_2_13_158_1 e_1_2_13_135_1 e_1_2_13_177_1 e_1_2_13_51_1 e_1_2_13_74_1 e_1_2_13_173_1 e_1_2_13_70_1 e_1_2_13_150_1 e_1_2_13_4_1 Menendez M (e_1_2_13_108_1) 2004; 6 e_1_2_13_105_1 e_1_2_13_88_1 e_1_2_13_128_1 e_1_2_13_29_1 e_1_2_13_109_1 Brickell KL (e_1_2_13_20_1) 2007; 78 e_1_2_13_25_1 e_1_2_13_48_1 e_1_2_13_165_1 e_1_2_13_100_1 e_1_2_13_142_1 e_1_2_13_44_1 e_1_2_13_67_1 e_1_2_13_169_1 e_1_2_13_104_1 e_1_2_13_123_1 e_1_2_13_86_1 e_1_2_13_146_1 e_1_2_13_9_1 e_1_2_13_40_1 e_1_2_13_63_1 e_1_2_13_82_1 e_1_2_13_184_1 e_1_2_13_161_1 e_1_2_13_180_1 e_1_2_13_91_1 e_1_2_13_95_1 e_1_2_13_116_1 e_1_2_13_99_1 e_1_2_13_139_1 e_1_2_13_18_1 e_1_2_13_14_1 e_1_2_13_111_1 e_1_2_13_130_1 e_1_2_13_153_1 e_1_2_13_37_1 e_1_2_13_79_1 Oberstein SA (e_1_2_13_121_1) 2003; 60 e_1_2_13_10_1 e_1_2_13_56_1 e_1_2_13_115_1 e_1_2_13_134_1 e_1_2_13_157_1 e_1_2_13_176_1 e_1_2_13_33_1 e_1_2_13_75_1 e_1_2_13_52_1 e_1_2_13_172_1 e_1_2_13_71_1 e_1_2_13_5_1 e_1_2_13_127_1 e_1_2_13_49_1 e_1_2_13_122_1 e_1_2_13_141_1 e_1_2_13_164_1 e_1_2_13_26_1 e_1_2_13_68_1 e_1_2_13_45_1 e_1_2_13_126_1 e_1_2_13_87_1 e_1_2_13_145_1 e_1_2_13_168_1 e_1_2_13_22_1 e_1_2_13_64_1 e_1_2_13_103_1 e_1_2_13_60_1 e_1_2_13_83_1 e_1_2_13_183_1 e_1_2_13_6_1 e_1_2_13_160_1 e_1_2_13_90_1 e_1_2_13_94_1 e_1_2_13_98_1 e_1_2_13_119_1 e_1_2_13_138_1 e_1_2_13_19_1 e_1_2_13_133_1 e_1_2_13_179_1 e_1_2_13_15_1 e_1_2_13_38_1 e_1_2_13_57_1 e_1_2_13_110_1 e_1_2_13_152_1 e_1_2_13_137_1 e_1_2_13_175_1 e_1_2_13_11_1 e_1_2_13_34_1 e_1_2_13_53_1 e_1_2_13_76_1 e_1_2_13_114_1 e_1_2_13_156_1 e_1_2_13_171_1 e_1_2_13_30_1 e_1_2_13_72_1 EUROCJD (e_1_2_13_41_1) 2001; 157 e_1_2_13_2_1 e_1_2_13_107_1 e_1_2_13_149_1 e_1_2_13_144_1 e_1_2_13_27_1 e_1_2_13_46_1 e_1_2_13_69_1 Broustal O (e_1_2_13_21_1) 2010; 22 e_1_2_13_163_1 e_1_2_13_102_1 e_1_2_13_125_1 e_1_2_13_148_1 e_1_2_13_23_1 e_1_2_13_42_1 e_1_2_13_65_1 e_1_2_13_167_1 e_1_2_13_84_1 e_1_2_13_182_1 e_1_2_13_7_1 e_1_2_13_61_1 e_1_2_13_80_1 e_1_2_13_140_1 e_1_2_13_93_1 e_1_2_13_97_1 e_1_2_13_118_1 e_1_2_13_39_1 e_1_2_13_132_1 e_1_2_13_155_1 e_1_2_13_178_1 e_1_2_13_35_1 e_1_2_13_16_1 e_1_2_13_58_1 e_1_2_13_113_1 e_1_2_13_136_1 e_1_2_13_159_1 e_1_2_13_174_1 e_1_2_13_31_1 e_1_2_13_77_1 e_1_2_13_12_1 e_1_2_13_54_1 e_1_2_13_170_1 e_1_2_13_73_1 e_1_2_13_50_1 e_1_2_13_151_1 e_1_2_13_3_1 e_1_2_13_106_1 e_1_2_13_129_1 e_1_2_13_89_1 e_1_2_13_28_1 |
| References_xml | – reference: Ghidoni R, Benussi L, Glionna M, Franzoni M, Binetti G. 2008. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 71: 1235-1239. – reference: Small SA, Duff K. 2008. Linking Abeta and tau in late-onset Alzheimer's disease: A dual pathway hypothesis. Neuron 60: 534-542. – reference: Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M. 2011. Classification of primary progressive aphasia and its variants. Neurology 76: 1006-1014. – reference: Tanahashi H, Kawakatsu S, Kaneko M, Yamanaka H, Takahashi K, Tabira T. 1996. Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer's disease patients. Neurosci Lett 218: 139-141. – reference: Halliday GM, Song YJ, Lepar G, Brooks WS, Kwok JB, Kersaitis C, Gregory G, Shepherd CE, Rahimi F, Schofield PR, Kril JJ. 2005. Pick bodies in a family with presenilin-1 Alzheimer's disease. Ann Neurol 57: 139-143. – reference: Munoz DG, Ros R, Fatas M, Bermejo F, de Yebenes JG. 2007. Progressive nonfluent aphasia associated with a new mutation V363I in tau gene. Am J Alzheimers Dis Other Demen 22: 294-299. – reference: Nervi A, Reitz C, Tang MX, Santana V, Piriz A, Reyes D, Lantigua R, Medrano M, Jimenez-Velazquez IZ, Lee JH, Mayeux R. 2011. Familial aggregation of dementia with Lewy bodies. Arch Neurol 68: 90-93. – reference: Rizzu P, van Mil SE, Anar B, Rosso SM, Donker Kaat L, Heutink P, van Swieten JC. 2006. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia. Am J Med Genet Part B 141B: 944-946. – reference: Schumacher A, Friedrich P, Diehl-Schmid J, Ibach B, Pernechzky R, Eisele T, Vukovich R, Foerstl H, Riemenschneider M. 2009. No association of TDP-43 with sporadic frontotemporal dementia. Neurobiol Aging 30: 157-159. – reference: Clark RF, Hutton M, Fuldner M, Froelich S, Karran E, Talbot C, Crook R, Lendon C, Prihar G, He C, Korenblat K, Martinez A, Wragg W, Busfield F, Behrens MI, Myers A, Norton J, Morris J, Mehta N, Pearson C, Lincoln S, Baker M, Duff K, Zehr C, Perez-Tur J, Houlden H, Ruiz A, Ossa J, Lopera F, Acros M, Madrigal L, Collinge J, Humphreys C, Ashwordth A, Sarner S, Fox N, Harvey R, Kennedy A, Roques P, Cline RT, Philips CA, Venter JC, Forsell L, Axelman K, Lilius L, Johnston J, Cowburn R, Viitanen M, Winblad B, Kosik K, Haltia M, Poyhonen M, Dickson D, Mann D, Neary D, Snowden J, Lantos P, Lannfelt L, Rossor M, Roberts GW, Adams MD, Hardy J, Goate A. 1995. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Alzheimer's Disease Collaborative Group. Nat Genet 11: 219-222. – reference: Mead S, Webb TEF, Campbell TA, Beck J, Linehan JM, Rutherfoord S, Joiner S, Wadsworth JDF, Heckmann J, Wroe S, Doey L, King A, Collinge J. 2007. Inherited prion disease with 5-OPRI: Phenotype modification by repeat length and codon 129. Neurology 69: 730-738. – reference: Papageorgiou SG, Kontaxis T, Bonakis A, Kalfakis N, Vassilopoulos D. 2009. Frequency and causes of early-onset dementia in a tertiary referral center in Athens. Alzheimer Dis Assoc Disord 23: 347-351. – reference: Lindquist SG, Holm IE, Schwartz M, Law I, Stokholm J, Batbayli M, Waldemar G, Nielsen JE. 2008. Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. Eur J Neurol 15: 377-385. – reference: McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CRJ, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. 2011. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 263-269. – reference: Raux G, Gantier R, Thomas-Anterion C, Boulliat J, Verpillat P, Hannequin D, Brice A, Frebourg T, Campion D. 2000. Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation. Neurology 55: 1577-1578. – reference: Ostojic J, Elfgren C, Passant U, Nilsson K, Gustafson L, Lannfelt L, Froelich Fabre S. 2004. The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy. Dement Geriatr Cogn Disord 17: 298-2301. – reference: van der Zee J, Pirici D, van Langenhove T, Engelborghs S, Vandenberghe R, Hoffmann M, Pusswald G, Van den Broeck M, Peeters K, Mattheijssens M, Martin JJ, de Deyn PP, Cruts M, Haubenberger D, Kumar-Singh S, Zimprich A, Van Broeckhoven C. 2009. Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His. Neurology 73: 626-632. – reference: Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R, Bisceglio G, Rovelet-Lecrux A, Boeve B, Petersen RC, Dickson DW, Younkin SG, Deramecourt V, Crook J, Graff-Radford NR, Rademakers R. 2009. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132: 583-591. – reference: Neumann M, Tolnay M, Mackenzie IRA. 2009. The molecular basis of frontotemporal dementia. Expert Rev Mol Med 11: e23. – reference: Alzualde A, Moreno F, Martinez-Lage P, Ferrer I, Gorostidi A, Otaegui D, Blazquez L, Atares B, Cardoso S, Martinez de Pancorbo M, Juste R, Rodriguez-Martinez AB, Indakoetxea B, Lopez de Munain A. 2010. Somatic mosaicism in a case of apparently sporadic Creutzfeldt-Jakob disease carrying a de novo D178N mutation in the PRNP gene. Am J Med Genet Part B 153B: 1283-1291. – reference: Burgunder JM, Finsterer J, Szolnoki Z, Fontaine B, Baets J, Van Broeckhoven C, Di Donato S, de Jonghe P, Lynch T, Mariotti C, Schols L, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Gasser T. 2010. EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias. Eur J Neurol 17: 641-648. – reference: Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, Galloway NM, Feldman H, Woltjer R, Miller CA, Wood EM, Grossman M, McCluskey L, Clark CM, Neumann M, Danek A, Galasko DR, Arnold SE, Chen-Plotkin A, Karydas A, Miller BL, Trojanowski JQ, Lee VMY, Schellenberg GD, Van Deerlin VM. 2010. The spectrum of mutations in progranulin: A collaborative study screening 545 cases of neurodegeneration. Arch Neurol 67: 161-170. – reference: Schofield EC, Halliday GM, Kwok J, Loy C, Double KL, Hodges JR. 2010. Low serum progranulin predicts the presence of mutations: A prospective study. J Alzheimers Dis 22: 981-984. – reference: Green RC, Cupples LA, Go R, Benke KS, Edeki T, Griffith PA, Williams M, Hipps Y, Graff-Radford N, Bachman D, Farrer LA. 2002. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA 287: 329-336. – reference: Portet F, Dauvilliers Y, Campion D, Raux G, Hauw JJ, Lyon-Caen O, Camu W, Touchon J. 2003. Very early onset AD with a de novo mutation in the presenilin 1 gene (Met 233 Leu). Neurology 61: 1136-1137. – reference: Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, Beck J, Isaacs AM, Authier A, Ferrari R, Fox NC, Mackenzie IR, Warren JD, de Silva R, Holton J, Revesz T, Hardy J, Mead S, Rossor MN. 2009. The heritability and genetics of frontotemporal lobar degeneration. Neurology 73: 1451-1456. – reference: Boeve BF, Tremont-Lukats IW, Waclawik AJ, Murrell JR, Hermann B, Jack CRJ, Shiung MM, Smith GE, Nair AR, Lindor N, Koppikar V, Ghetti B. 2005. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. Brain 128: 752-772. – reference: Biffi A, Greenberg SM. 2011. Cerebral amyloid angiopathy: A systematic review. J Clin Neurol 7: 1-9. – reference: Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297: 353-356. – reference: Brouwers N, Sleegers K, Engelborghs S, Bogaerts V, Serneels S, Kamali K, Corsmit E, de Leenheir E, Martin JJ, de Deyn PP, Van Broeckhoven C, Theuns J. 2006. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brain 129: 2984-2991. – reference: Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, Bi W, Hoge JA, Cohen AD, Ikonomovic MD, Saxton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, Swearer JM, Johnson KA, Rentz DM, Fischman AJ, Aizenstein HJ, DeKosky ST. 2007. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 27: 6174-6184. – reference: Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet-Lecrux A, Hahn-Barma V, van der Zee J, Clot F, Bakchine S, Puel M, Ghanim M, Lacomblez L, Mikol J, Deramecourt V, Lejeune P, de la Sayette V, Belliard S, Vercelletto M, Meyrignac C, Van Broeckhoven C, Lambert JC, Verpillat P, Campion D, Habert MO, Dubois B, Brice A. 2008. Phenotype variability in progranulin mutation carriers: A clinical, neuropsychological, imaging and genetic study. Brain 131: 732-746. – reference: Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, Kemppainen N, Nagren K, Kim BC, Tsui W, de Leon MJ. 2008. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging 35: 2169-2181. – reference: McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944. – reference: Sleegers K, Brouwers N, Gijselinck I, Theuns J, Goossens D, Wauters J, Del-Favero J, Cruts M, van Duijn CM, Van Broeckhoven C. 2006. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 129: 2977-2983. – reference: Scholl M, Almkvist O, Axelman K, Stefanova E, Wall A, Westman E, Langstrom B, Lannfelt L, Graff C, Nordberg A. 2011. Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation. Neurobiol Aging 32: 1388-1399. – reference: Anfossi M, Bernardi L, Gallo M, Geracitano S, Colao R, Puccio G, Curcio SA, Frangipane F, Mirabelli M, Tomaino C, Smirne N, Maletta R, Bruni AC. 2011. MAPT V363I variation in a sporadic case of frontotemporal dementia: Variable penetrant mutation or rare polymorphism? Alzheimer Dis Assoc Disord 25: 96-99. – reference: Moonis M, Swearer JM, Dayaw MPE, St George-Hyslop P, Rogaeva E, Kawarai T, Pollen DA. 2005. Familial Alzheimer disease: Decreases in CSF Abeta42 levels precede cognitive decline. Neurology 65: 323-325. – reference: Borroni B, Archetti S, Alberici A, Agosti C, Gennarelli M, Bigni B, Bonvicini C, Ferrari M, Bellelli G, Galimberti D, Scarpini E, Di Lorenzo D, Caimi L, Caltagirone C, Di Luca M, Padovani A. 2008. Progranulin genetic variations in frontotemporal lobar degeneration: Evidence for low mutation frequency in an Italian clinical series. Neurogenetics 9: 197-205. – reference: Jayadev S, Nochlin D, Poorkaj P, Steinbart EJ, Mastrianni JA, Montine TJ, Ghetti B, Schellenberg GD, Bird TD, Leverenz JB. 2011. Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype. Ann Neurol 69: 712-720. – reference: Kovacs GG, Murrell JR, Horvath S, Haraszti L, Majtenyi K, Molnar MJ, Budka H, Ghetti B, Spina S. 2009. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord 24: 1843-1847. – reference: Quaid K. 2011. Genetic counseling for frontotemporal dementias. J Mol Neurosci 45: 706-709. – reference: Rollinson S, Snowden JS, Neary D, Morrison KE, Mann DM, Pickering-Brown SM. 2007. TDP-43 gene analysis in frontotemporal lobar degeneration. Neurosci Lett 419: 1-4. – reference: Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, Dubas F, Frebourg T, Campion D. 2006. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38: 24-26. – reference: Menendez M. 2004. Pathological and clinical heterogeneity of presenilin 1 gene mutations. J Alzheimers Dis 6: 475-482. – reference: Ladogana A, Sanchez-Juan P, Mitrova E, Green A, Cuadrado-Corrales N, Sanchez-Valle R, Koscova S, Aguzzi A, Sklaviadis T, Kulczycki J, Gawinecka J, Saiz A, Calero M, van Duijn CM, Pocchiari M, Knight R, Zerr I. 2009. Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol 256: 1620-1628. – reference: Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J, Bettens K, Van Cauwenberghe C, Pereson S, Engelborghs S, Sieben A, De Jonghe P, Vandenberghe R, Santens P, De Bleecker J, Maes G, Baumer V, Dillen L, Joris G, Cuijt I, Corsmit E, Elinck E, Van Dongen J, Vermeulen S, Van den Broeck M, Vaerenberg C, Mattheijssens M, Peeters K, Robberecht W, Cras P, Martin JJ, De Deyn PP, Cruts M, Van Broeckhoven C. 2012. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: A gene identification study. Lancet Neurol 11: 54-65. – reference: Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, Nielsen JE, Hodges JR, Spillantini MG, Thusgaard T, Brandner S, Brun A, Rossor MN, Gade A, Johannsen P, Sorensen SA, Gydesen S, Fisher EM, Collinge J. 2005. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 37: 806-808. – reference: McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH. 1996. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47: 1113-1124. – reference: Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M. 2006. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442: 916-919. – reference: Poorkaj P, Grossman M, Steinbart E, Payami H, Sadovnick A, Nochlin D, Tabira T, Trojanowski JQ, Borson S, Galasko D, Reich S, Quinn B, Schellenberg G, Bird TD. 2001. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol 58: 383-387. – reference: Momeni P, DeTucci K, Straub RE, Weinberger DR, Davies P, Grafman J, Hardy J, Huey ED. 2010. Progranulin (GRN) in two siblings of a Latino family and in other patients with schizophrenia. Neurocase 16: 273-279. – reference: Majounie E, Abramzon Y, Renton AE, Perry R, Bassett SS, Pletnikova O, Troncoso JC, Hardy J, Singleton AB, Traynor BJ. 2012. Repeat expansion in C9ORF72 in Alzheimer's disease. N Engl J Med 366: 283-284. – reference: Chen-Plotkin AS, Martinez-Lage M, Sleiman PMA, Hu W, Greene R, Wood EM, Bing S, Grossman M, Schellenberg GD, Hatanpaa KJ, Weiner MF, White CL, Brooks WS, Halliday GM, Kril JJ, Gearing M, Beach TG, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Pickering-Brown SM, Snowden J, van Swieten JC, Heutink P, Seelaar H, Murrell JR, Ghetti B, Spina S, Grafman J, Kaye JA, Woltjer RL, Mesulam M, Bigio E, Llado A, Miller BL, Alzualde A, Moreno F, Rohrer JD, Mackenzie IRA, Feldman HH, Hamilton RL, Cruts M, Engelborghs S, de Deyn PP, Van Broeckhoven C, Bird TD, Cairns NJ, Goate A, Frosch MP, Riederer PF, Bogdanovic N, Lee VMY, Trojanowski JQ, Van Deerlin VM. 2011. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol 68: 488-497. – reference: Devi G, Ottman R, Tang MX, Marder K, Stern Y, Mayeux R. 2000. Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan. Arch Neurol 57: 72-77. – reference: Dermaut B, Kumar-Singh S, Engelborghs S, Theuns J, Rademakers R, Saerens J, Pickut BA, Peeters K, Van den Broeck M, Vennekens K, Claes S, Cruts M, Cras P, Martin JJ, Van BC, de Deyn PP. 2004. A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol 55: 617-626. – reference: Lleo A, Blesa R, Queralt R, Ezquerra M, Molinuevo JL, Pena-Casanova J, Rojo A, Oliva R. 2002. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain. Arch Neurol 59: 1759-1763. – reference: Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Moriwaka F, Shiga Y, Kuroiwa Y, Nishizawa M, Kuzuhara S, Inuzuka T, Takeda M, Kuroda S, Abe K, Murai H, Murayama S, Tateishi J, Takumi I, Shirabe S, Harada M, Sadakane A, Yamada M. 2010. Prospective 10-year surveillance of human prion diseases in Japan. Brain 133: 3043-3057. – reference: Alberici A, Bonato C, Borroni B, Cotelli M, Mattioli F, Binetti G, Gennarelli M, Luca MD, Simonati A, Perani D, Rossini P, Padovani A. 2007. Dementia, delusions and seizures: Storage disease or genetic AD? Eur J Neurol 14: 1057-1059. – reference: Reed LA, Wszolek ZK, Hutton M. 2001. Phenotypic correlations in FTDP-17. Neurobiol Aging 22: 89-107. – reference: Larner AJ, Doran M. 2006. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol 253: 139-158. – reference: Murray M, Dejesus-Hernandez M, Rutherford N, Baker M, Duara R, Graff-Radford N, Wszolek Z, Ferman T, Josephs K, Boylan K, Rademakers R, Dickson D. 2011. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol 122: 673-690. – reference: Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P, Cantwell LB, Dombroski BA, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Lunetta KL, Martin ER, Montine TJ, Goate AM, Blacker D, Tsuang DW, Beekly D, Cupples LA, Hakonarson H, Kukull W, Foroud TM, Haines J, Mayeux R, Farrer LA, Pericak-Vance MA, Schellenberg GD. 2010. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 67: 1473-1484. – reference: Kauwe JSK, Jacquart S, Chakraverty S, Wang J, Mayo K, Fagan AM, Holtzman DM, Morris JC, Goate AM. 2007. Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation. Ann Neurol 61: 446-453. – reference: Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD. 1994. The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 44: 1683-1686. – reference: Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, de Deyn PP, Van BC, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J. 2009. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088-1093. – reference: Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. 1998. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 95: 7737-7741. – reference: Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, de Jong D, Dooijes D, Kamphorst W, Ravid R, Niermeijer MF, Verheij F, Kremer HP, Scheltens P, van Duijn CM, Heutink P, van Swieten JC. 2003. Frontotemporal dementia in The Netherlands: Patient characteristics and prevalence estimates from a population-based study. Brain 126: 2016-2022. – reference: Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, Authier A, Seelaar H, van Swieten JC, Brown JM, Johannsen P, Nielsen JE, Holm IE, Dickson DW, Rademakers R, Graff-Radford NR, Parisi JE, Petersen RC, Hatanpaa KJ, White CL III, Weiner MF, Geser F, Van Deerlin VM, Trojanowski JQ, Miller BL, Seeley WW, van der Zee J, Kumar-Singh S, Engelborghs S, de Deyn PP, Van Broeckhoven C, Bigio EH, Deng HX, Halliday GM, Kril JJ, Munoz DG, Mann DM, Pickering-Brown SM, Doodeman V, Adamson G, Ghazi-Noori S, Fisher EM, Holton JL, Revesz T, Rossor MN, Collinge J, Mead S, Isaacs AM. 2010. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol 120: 33-41. – reference: Leyton C, Villemagne V, Savage S, Pike K, Ballard K, Piguet O, Burrell J, Rowe C, Hodges J. 2011. Subtypes of progressive aphasia: Application of the international consensus criteria and validation using {beta}-amyloid imaging. Brain 134: 3030-3043. – reference: Seelaar H, Kamphorst W, Rosso SM, Azmani A, Masdjedi R, de Koning I, Maat-Kievit JA, Anar B, Donker KL, Breedveld GJ, Dooijes D, Rozemuller JM, Bronner IF, Rizzu P, van Swieten JC. 2008. Distinct genetic forms of frontotemporal dementia. Neurology 71: 1220-1226. – reference: Schoder D, Hannequin D, Martinaud O, Opolczynski G, Guyant-Marechal L, Le Ber I, Campion D. 2010. Morbid risk for schizophrenia in first-degree relatives of people with frontotemporal dementia. Br J Psychiatry 197: 28-35. – reference: Kaivorinne AL, Kruger J, Kuivaniemi K, Tuominen H, Moilanen V, Majamaa K, Remes AM. 2008. Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland. BMC Neurol 8: 48. – reference: van der Zee J, Urwin H, Engelborghs S, Bruyland M, Vandenberghe R, Dermaut B, de Pooter T, Peeters K, Santens P, de Deyn PP, Fisher EM, Collinge J, Isaacs AM, Van Broeckhoven C. 2008. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet 17: 313-322. – reference: Broustal O, Camuzat A, Guillot-Noel L, Guy N, Millecamps S, Deffond D, Lacomblez L, Golfier V, Hannequin D, Salachas F, Camu W, Didic M, Dubois B, Meininger V, Le B I, Brice A. 2010. FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis. J Alzheimers Dis 22: 765-769. – reference: Queralt R, Ezquerra M, Lleo A, Castellvi M, Gelpi J, Ferrer I, Acarin N, Pasarin L, Blesa R, Oliva R. 2002. A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances. J Neurol Neurosurg Psychiatry 72: 266-269. – reference: Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, Bullido MJ, Engelborghs S, de Deyn P, Berr C, Pasquier F, Dubois B, Tognoni G, Fievet N, Brouwers N, Bettens K, Arosio B, Coto E, Del Zompo M, Mateo I, Epelbaum J, Frank-Garcia A, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Valdivieso F, Vepsalainen S, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Hanon O, Piccardi P, Annoni G, Seripa D, Galimberti D, Licastro F, Soininen H, Dartigues JF, Kamboh MI, Van Broeckhoven C, Lambert JC, Amouyel P, Campion D. 2011. APOE and Alzheimer disease: A major gene with semi-dominant inheritance. Mol Psychiatry 16: 903-907. – reference: Alzheimer's Association. 2011. 2011 Alzheimer's disease facts and figures. Alzheimers Dement 7: 208-244. – reference: Helzner EP, Scarmeas N, Cosentino S, Tang MX, Schupf N, Stern Y. 2008. Survival in Alzheimer disease: A multiethnic, population-based study of incident cases. Neurology 71: 1489-1495. – reference: Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JB, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P. 1998. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702-705. – reference: Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Green RC. 2005. Genetic risk assessment for adult children of people with Alzheimer's disease: The Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study. J Geriatr Psychiatry Neurol 18: 250-255. – reference: Wardle M, Morris HR, Robertson NP. 2009. Clinical and genetic characteristics of non-Asian dentatorubral-pallidoluysian atrophy: A systematic review. Mov Disord 24: 1636-1640. – reference: Bian H, van Swieten JC, Leight S, Massimo L, Wood E, Forman M, Moore P, de Koning I, Clark CM, Rosso S, Trojanowski J, Lee VMY, Grossman M. 2008. CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 70: 1827-1835. – reference: Oberstein SA. 2003. Diagnostic strategies in CADASIL. Neurology 60: 2020. – reference: Burrell JR, Kiernan MC, Vucic S, Hodges JR. 2011. Motor neuron dysfunction in frontotemporal dementia. Brain 134: 2582-2594. – reference: Harvey RJ, Skelton-Robinson M, Rossor MN. 2003. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 74: 1206-1209. – reference: McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. 2001. Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58: 1803-1809. – reference: Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Holtta-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chio A, Restagno G, Borghero G, Sabatelli M, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ. 2011. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257-268. – reference: Mead S, Poulter M, Beck J, Webb TEF, Campbell TA, Linehan JM, Desbruslais M, Joiner S, Wadsworth JDF, King A, Lantos P, Collinge J. 2006. Inherited prion disease with six octapeptide repeat insertional mutation-Molecular analysis of phenotypic heterogeneity. Brain 129: 2297-2317. – reference: Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. 2005. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65: 586-590. – reference: Cruts M, van Duijn CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S, Sherrington R, Hutton M, Hardy J, St George-Hyslop PH, Hofman A, Van BC. 1998. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 7: 43-51. – reference: Yan J, Deng HX, Siddique N, Fecto F, Chen W, Yang Y, Liu E, Donkervoort S, Zheng JG, Shi Y, Ahmeti KB, Brooks B, Engel WK, Siddique T. 2010. Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology 75: 807-814. – reference: Rascovsky K, Hodges J, Knopman D, Mendez M, Kramer J, Neuhaus J, van Swieten J, Seelaar H, Dopper E, Onyike C, Hillis A, Josephs K, Boeve B, Kertesz A, Seeley W, Rankin K, Johnson J, Gorno-Tempini M, Rosen H, Prioleau-Latham C, Lee A, Kipps C, Lillo P, Piguet O, Rohrer J, Rossor M, Warren J, Fox N, Galasko D, Salmon D, Black S, Mesulam M, Weintraub S, Dickerson B, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow T, Manes F, Grafman J, Cappa S, Freedman M, Grossman M, Miller B. 2011. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134: 2456-2477. – reference: Mendez MF, McMurtray A. 2006. Frontotemporal dementia-like phenotypes associated with presenilin-1 mutations. Am J Alzheimers Dis Other Demen 21: 281-286. – reference: Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE. 2004. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36: 377-381. – reference: Fabre SF, Forsell C, Viitanen M, Sjogren M, Wallin A, Blennow K, Blomberg M, Andersen C, Wahlund LO, Lannfelt L. 2001. Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations. Exp Neurol 168: 413-418. – reference: Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L. 1992. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1: 345-347. – reference: Arango D, Cruts M, Torres O, Backhovens H, Serrano ML, Villareal E, Montanes P, Matallana D, Cano C, Van Broeckhoven C, Jacquier M. 2001. Systematic genetic study of Alzheimer disease in Latin America: Mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia. Am J Med Genet 103: 138-143. – reference: Piguet O, Hornberger M, Mioshi E, Hodges JR. 2011. Behavioural-variant frontotemporal dementia: Diagnosis, clinical staging, and management. Lancet Neurol 10: 162-172. – reference: Mok K, Traynor B, Schymick J, Tienari P, Laaksovirta H, Peuralinna T, Myllykangas L, Chio A, Shatunov A, Boeve B, Boxer A, Dejesus-Hernandez M, Mackenzie I, Waite A, Williams N, Morris H, Simon-Sanchez J, van Swieten J, Heutink P, Restagno G, Mora G, Morrison K, Shaw P, Rollinson P, Al-Chalabi A, Rademakers R, Pickering-Brown S, Orrell R, Nalls M, Hardy J. 2012. The chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging 209.e3-209.e8. – reference: Seelaar H, Klijnsma KY, de Koning I, van der Lugt A, Chiu WZ, Azmani A, Rozemuller AJ, van Swieten JC. 2010. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J Neurol 257: 747-753. – reference: Pimplikar SW, Nixon RA, Robakis NK, Shen J, Tsai LH. 2010. Amyloid-independent mechanisms in Alzheimer's disease pathogenesis. J Neurosci 30: 14946-14954. – reference: Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, Pedersen NL. 2006. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63: 168-174. – reference: Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J, Lomen-Hoerth C, Wilhelmsen KC, Lee VMY, Grossman M, Miller BL. 2005. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 65: 1817-1819. – reference: Jack CRJ, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC. 2009. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease. Brain 132: 1355-1365. – reference: Blom ES, Viswanathan J, Kilander L, Helisalmi S, Soininen H, Lannfelt L, Ingelsson M, Glaser A, Hiltunen M. 2008. Low prevalence of APP duplications in Swedish and Finnish patients with early-onset Alzheimer's disease. Eur J Hum Genet 16: 171-175. – reference: Whitwell JL, Jack CR Jr, Boeve BF, Senjem ML, Baker M, Rademakers R, Ivnik RJ, Knopman DS, Wszolek ZK, Petersen RC, Josephs KA. 2009. Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology 72: 813-820. – reference: Carecchio M, Fenoglio C, de Riz M, Guidi I, Comi C, Cortini F, Venturelli E, Restelli I, Cantoni C, Bresolin N, Monaco F, Scarpini E, Galimberti D. 2009. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease. J Neurol Sci 287: 291-293. – reference: Jayadev S, Leverenz JB, Steinbart E, Stahl J, Klunk W, Yu CE, Bird TD. 2010. Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. Brain 133: 1143-1154. – reference: Romero LJ, Garry PJ, Schuyler M, Bennahum DA, Qualls C, Ballinger L, Kelly V, Schmitt C, Skipper B, Ortiz IE, Rhyne RL. 2005. Emotional responses to APO E genotype disclosure for Alzheimer disease. J Genet Couns 14: 141-150. – reference: Finckh U, Muller-Thomsen T, Mann U, Eggers C, Marksteiner J, Meins W, Binetti G, Alberici A, Hock C, Nitsch RM, Gal A. 2000. High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. Am J Hum Genet 66: 110-117. – reference: Rogaeva EA, Fafel KC, Song YQ, Medeiros H, Sato C, Liang Y, Richard E, Rogaev EI, Frommelt P, Sadovnick AD, Meschino W, Rockwood K, Boss MA, Mayeux R, St George-Hyslop P. 2001. Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology 57: 621-625. – reference: Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rossor MN, Collinge J. 2003. Early onset familial Alzheimer's disease: Mutation frequency in 31 families. Neurology 60: 235-239. – reference: Stevens M, van Duijn CM, Kamphorst W, de Knijff P, Heutink P, van Gool WA, Scheltens P, Ravid R, Oostra BA, Niermeijer MF, van Swieten JC. 1998. Familial aggregation in frontotemporal dementia. Neurology 50: 1541-1545. – reference: Dagvadorj A, Petersen RB, Lee HS, Cervenakova L, Shatunov A, Budka H, Brown P, Gambetti P, Goldfarb LG. 2002. Spontaneous mutations in the prion protein gene causing transmissible spongiform encephalopathy. Ann Neurol 52: 355-359. – reference: Ikejima C, Yasuno F, Mizukami K, Sasaki M, Tanimukai S, Asada T. 2009. Prevalence and causes of early-onset dementia in Japan: A population-based study. Stroke 40: 2709-2714. – reference: Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF. 1998. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51: 1546-1554. – reference: Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, Gass J, Cannon A, Rademakers R, Hutton M, Feldman HH. 2006. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 129: 3081-3090. – reference: van Langenhove T, van der Zee J, Sleegers K, Engelborghs S, Vandenberghe R, Gijselinck I, Van den Broeck M, Mattheijssens M, Peeters K, de Deyn PP, Cruts M, Van Broeckhoven C. 2010. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology 74: 366-371. – reference: Ratnavalli E, Brayne C, Dawson K, Hodges JR. 2002. The prevalence of frontotemporal dementia. Neurology 58: 1615-1621. – reference: Breitner JC. 1991. Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med 115: 601-606. – reference: Koedam ELGE, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YAL. 2010. Early-versus late-onset Alzheimer's disease: More than age alone. J Alzheimers Dis 19: 1401-1408. – reference: Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, Forman M, Chute DJ, Roberson ED, Pace-Savitsky C, Neumann M, Chow TW, Rosen HJ, Forstl H, Kurz A, Miller BL. 2005. Frontotemporal lobar degeneration: Demographic characteristics of 353 patients. Arch Neurol 62: 925-930. – reference: Villemagne VL, Ataka S, Mizuno T, Brooks WS, Wada Y, Kondo M, Jones G, Watanabe Y, Mulligan R, Nakagawa M, Miki T, Shimada H, O'Keefe GJ, Masters CL, Mori H, Rowe CC. 2009. High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol 66: 1537-1544. – reference: Borroni B, Bonvicini C, Alberici A, Buratti E, Agosti C, Archetti S, Papetti A, Stuani C, Di Luca M, Gennarelli M, Padovani A. 2009. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum Mutat 30: E974-E983. – reference: Rohrer JD, Warren JD, Omar R, Mead S, Beck J, Revesz T, Holton J, Stevens JM, Al-Sarraj S, Pickering-Brown SM, Hardy J, Fox NC, Collinge J, Warrington EK, Rossor MN. 2008. Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol 65: 506-513. – reference: Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H. 2002. Mutations of the prion protein gene phenotypic spectrum. J Neurol 249: 1567-1582. – reference: Shankaran SS, Capell A, Hruscha AT, Fellerer K, Neumann M, Schmid B, Haass C. 2008. Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. J Biol Chem 283: 1744-1753. – reference: Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, Chen C, Cook-Deegan R, Farrer LA. 2009. Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 361: 245-254. – reference: Herve D, Chabriat H. 2010. CADASIL. J Geriatr Psychiatry Neurol 23: 269-276. – reference: Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, Gibbs JR, Brunetti M, Gronka S, Wuu J, Ding J, McCluskey L, Martinez-Lage M, Falcone D, Hernandez DG, Arepalli S, Chong S, Schymick JC, Rothstein J, Landi F, Wang YD, Calvo A, Mora G, Sabatelli M, Monsurro MR, Battistini S, Salvi F, Spataro R, Sola P, Borghero G, Galassi G, Scholz SW, Taylor JP, Restagno G, Chio A, Traynor BJ. 2010. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68: 857-864. – reference: EUROCJD. 2001. Genetic epidemiology of Creutzfeldt-Jakob disease in Europe. Rev Neurol (Paris) 157: 633-637. – reference: Gijselinck I, Sleegers K, Engelborghs S, Robberecht W, Martin JJ, Vandenberghe R, Sciot R, Dermaut B, Goossens D, van der Zee J, de Pooter T, Del-Favero J, Santens P, de Jonghe P, de Deyn PP, Van Broeckhoven C, Cruts M. 2009. Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol Aging 30: 1329-1331. – reference: Fecto F, Siddique T. 2011. Making Connections: Pathology and Genetics Link Amyotrophic Lateral Sclerosis with Frontotemporal Lobe Dementia. J Mol Neurosci 45: 663-675. – reference: Le Ber I, van der Zee J, Hannequin D, Gijselinck I, Campion D, Puel M, Laquerriere A, de Pooter T, Camuzat A, Van den Broeck M, Dubois B, Sellal F, Lacomblez L, Vercelletto M, Thomas-Anterion C, Michel BF, Golfier V, Didic M, Salachas F, Duyckaerts C, Cruts M, Verpillat P, Van Broeckhoven C, Brice A. 2007. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat 28: 846-855. – reference: Steinbart EJ, Smith CO, Poorkaj P, Bird TD. 2001. Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia. Arch Neurol 58: 1828-1831. – reference: Deng H, Chen W, Hong S, Boycott K, Gorrie G, Siddique N, Yang Y, Fecto F, Shi y, Zhai H, Jiang H, Hirano M, Rampersaud E, Jansen G, Donkervoort S, Bigio E, Brooks B, Ajroud K, Sufit R, Haines J, Mugnaini E, Pericak-Vance M, Siddique T. 2011. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477: 211-215. – reference: Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, Wszolek Z, Gonzalez J, Beach TG, Bigio E, Johnson N, Weintraub S, Mesulam M, White CL III, Woodruff B, Caselli R, Hsiung GY, Feldman H, Knopman D, Hutton M, Rademakers R. 2006. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 15: 2988-3001. – reference: Snowden J, Rollinson S, Thompson J, Harris J, Stopford C, Richardson A, Jones M, Gerhard A, Davidson Y, Robinson A, Gibbons L, Hu Q, Duplessis D, Neary D, Mann D, Pickering-Brown S. 2012. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135: 693-708. – reference: Brickell KL, Leverenz JB, Steinbart EJ, Rumbaugh M, Schellenberg GD, Nochlin D, Lampe TH, Holm IE, Van D V, Yuan W, Bird TD. 2007. Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease. J Neurol Neurosurg Psychiatry 78: 1050-1055. – reference: Meeus B, Verstraeten A, Crosiers D, Engelborghs S, Van den Broeck M, Mattheijssens M, Peeters K, Corsmit E, Elinck E, Pickut B, Vandenberghe R, Cras P, De Deyn P, Van Broeckhoven C, Theuns J. 2012. DLB and PDD: A role for mutations in dementia and Parkinson disease genes? Neurobiol Aging 33: 629. – reference: Cannella M, Martino T, Simonelli M, Ciammola A, Gradini R, Ciarmiello A, Gianfrancesco F, Squitieri F. 2007. De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementia. J Neurol Neurosurg Psychiatry 78: 1411-1413. – reference: Pastor P, Pastor E, Carnero C, Vela R, Garcia T, Amer G, Tolosa E, Oliva R. 2001. Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene. Ann Neurol 49: 263-267. – reference: Hardy JA, Higgins GA. 1992. Alzheimer's disease: The amyloid cascade hypothesis. Science 256: 184-185. – reference: Johnson KA, Lopera F, Jones K, Becker A, Sperling R, Hilson J, Londono J, Siegert I, Arcos M, Moreno S, Madrigal L, Ossa J, Pineda N, Ardila A, Roselli M, Albert MS, Kosik KS, Rios A. 2001. Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology 56: 1545-1551. – reference: Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HA, Haines JL, Perkicak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760. – reference: Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ. 2007. Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study. Neurology 68: 501-508. – reference: Larner AJ, Ray PS, Doran M. 2007. The R269H mutation in presenilin-1 presenting as late-onset autosomal dominant Alzheimer's disease. J Neurol Sci 252: 173-176. – reference: Mercy L, Hodges JR, Dawson K, Barker RA, Brayne C. 2008. Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology 71: 1496-1499. – reference: Simon-Sanchez J, Dopper E, Cohn-Hokke P, Hukema R, Nicolaou N, Seelaar H, de Graaf J, de Koning I, van Schoor N, Deeg D, Smits M, Raaphorst J, van den Berg L, Schelhaas H, De Die-Smulders C, Majoor-Krakauer D, Rozemuller A, Willemsen R, Pijnenburg Y, Heutink P, van Swieten J. 2012. The clinical and pathological phenotype of C9orf72 hexanucleotide repeat expansions. Brain 135: 723-735. – reference: Revesz T, Holton JL, Lashley T, Plant G, Frangione B, Rostagno A, Ghiso J. 2009. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 118: 115-130. – reference: Van Swieten J, Spillantini MG. 2007. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol 17: 63-73. – reference: Thinakaran G, Koo EH. 2008. Amyloid precursor protein trafficking, processing, and function. J Biol Chem 283: 29615-29619. – reference: Beck JA, Poulter M, Campbell TA, Uphill JB, Adamson G, Geddes JF, Revesz T, Davis MB, Wood NW, Collinge J, Tabrizi SJ. 2004. Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease. Hum Mol Genet 13: 1219-1224. – reference: Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH, Powell JF. 2002. Diagnostic strategies in CADASIL. Neurology 59: 1134-1138. – reference: Goldman JS, Hahn SE, Catania JW, LaRusse-Eckert S, Butson MB, Rumbaugh M, Strecker MN, Roberts JS, Burke W, Mayeux R, Bird T. 2011. Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med 13: 597-605. – reference: Raux G, Guyant-Marechal L, Martin C, Bou J, Penet C, Brice A, Hannequin D, Frebourg T, Campion D. 2005. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: An update. J Med Genet 42: 793-795. – reference: Houlden H, Baker M, Adamson J, Grover A, Waring S, Dickson D, Lynch T, Boeve B, Petersen RC, Pickering-Brown S, Owen F, Neary D, Craufurd D, Snowden J, Mann D, Hutton M. 1999. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann Neurol 46: 243-248. – reference: Riedijk SR, Niermeijer MFN, Dooijes D, Tibben A. 2009. A decade of genetic counseling in frontotemporal dementia affected families: Few counseling requests and much familial opposition to testing. J Genet Couns 18: 350-356. – reference: Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ, van Duijn C, Peeters K, Sciot R, Santens P, de Pooter T, Mattheijssens M, Van den Broeck M, Cuijt I, Vennekens K, de Deyn PP, Kumar-Singh S, Van Broeckhoven C. 2006. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442: 920-924. – reference: Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, de Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van BC, Alperovitch A, Lathrop M, Amouyel P. 2009. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099. – reference: Peters N, Opherk C, Bergmann T, Castro M, Herzog J, Dichgans M. 2005. Spectrum of mutations in biopsy-proven CADASIL: Implications for diagnostic strategies. Arch Neurol 62: 1091-1094. – reference: Snowden JS, Hu Q, Rollinson S, Halliwell N, Robinson A, Davidson YS, Momeni P, Baborie A, Griffiths TD, Jaros E, Perry RH, Richardson A, Pickering-Brown SM, Neary D, Mann DM. 2011. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathol 122: 99-110. – reference: Tang-Wai D, Lewis P, Boeve B, Hutton M, Golde T, Baker M, Hardy J, Michels V, Ivnik R, Jack C, Petersen R. 2002. Familial frontotemporal dementia associated with a novel presenilin-1 mutation. Dement Geriatr Cogn Disord 14: 13-21. – reference: Golan MP, Styczynska M, Jozwiak K, Walecki J, Maruszak A, Pniewski J, Lugiewicz R, Filipek S, Zekanowski C, Barcikowska M. 2007. Early-onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene. Exp Neurol 208: 264-268. – reference: van der Zee J, Le Ber I, Maurer-Stroh S, Engelborghs S, Gijselinck I, Camuzat A, Brouwers N, Vandenberghe R, Sleegers K, Hannequin D, Dermaut B, Schymkowitz J, Campion D, Santens P, Martin JJ, Lacomblez L, de Pooter T, Peeters K, Mattheijssens M, Vercelletto M, Van den Broeck M, Cruts M, de Deyn PP, Rousseau F, Brice A, Van Broeckhoven C. 2007. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum Mutat 28: 416. – reference: Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM. 2001. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49: 697-705. – reference: Kelley BJ, Haidar W, Boeve BF, Baker M, Shiung M, Knopman DS, Rademakers R, Hutton M, Adamson J, Kuntz KM, Dickson DW, Parisi JE, Smith GE, Petersen RC. 2010. Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin. Arch Neurol 67: 171-177. – reference: Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, de Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, Green RC, Rogaeva E, George-Hyslop PS, Arnold SE, Barber R, Beach T, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Cummings JL, DeCarli C, DeKosky ST, Diaz-Arrastia R, Dick M, Dickson DW, Ellis WG, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Johnson N, Karlawish J, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Lah JJ, Levey AI, Lieberman AP, Lopez OL, Mack WJ, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, et al. 2011. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 43: 436-441. – reference: Brickell KL, Steinbart EJ, Rumbaugh M, Payami H, Schellenberg GD, Van Deerlin V, Yuan W, Bird TD. 2006. Early-onset Alzheimer disease in families with late-onset Alzheimer disease: A potential important subtype of familial Alzheimer disease. Arch Neurol 63: 1307-1311. – reference: Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706. – reference: van Herpen E, Rosso SM, Serverijnen LA, Yoshida H, Breedveld G, van de Graaf R, Kamphorst W, Ravid R, Willemsen R, Dooijes D, Majoor-Krakauer D, Kros JM, Crowther RA, Goedert M, Heutink P, van Swieten JC. 2003. Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R. Ann Neurol 54: 573-581. – reference: Cox LE, Ferraiuolo L, Goodall EF, Heath PR, Higginbottom A, Mortiboys H, Hollinger HC, Hartley JA, Brockington A, Burness CE, Morrison KE, Wharton SB, Grierson AJ, Ince PG, Kirby J, Shaw PJ. 2010. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS ONE 5: e9872. – reference: Bird TD. 2009. Progranulin plasma levels in the diagnosis of frontotemporal dementia. Brain 132: 568-569. – reference: Jansen C, Parchi P, Capellari S, Strammiello R, Dopper EGP, van Swieten JC, Kamphorst W, Rozemuller AJM. 2011. A second case of Gerstmann-Straussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. J Neuropathol Exp Neurol 70: 698-702. – reference: Hutton M. 2001. Missense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms. Neurology 56: S21-S25. – reference: Dejesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R. 2011. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72: 245-256. – reference: Pickering-Brown SM, Rollinson S, Du Plessis D, Morrison KE, Varma A, Richardson AMT, Neary D, Snowden JS, Mann DMA. 2008. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: Comparison with patients with MAPT and no known mutations. Brain 131: 721-731. – reference: Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, Syed NM, Lai Y, Lin EA, Kong L, Su J, Yin F, Ding AH, Zanin-Zhorov A, Dustin ML, Tao J, Craft J, Yin Z, Feng JQ, Abramson SB, Yu XP, Liu CJ. 2011. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332: 478-484. – reference: Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, Thomas-Anterion C, Michon A, Martin C, Charbonnier F, Raux G, Camuzat A, Penet C, Mesnage V, Martinez M, Clerget-Darpoux F, Brice A, Frebourg T. 1999. Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 65: 664-670. – reference: Christensen KD, Roberts JS, Royal CDM, Fasaye GA, Obisesan T, Cupples LA, Whitehouse PJ, Butson MB, Linnenbringer E, Relkin NR, Farrer L, Cook-Deegan R, Green RC. 2008. Incorporating ethnicity into genetic risk assessment for Alzheimer disease: The REVEAL study experience. Genet Med 10: 207-214. – reference: Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. 2010. The diagnosis of young-onset dementia. Lancet Neurol 9: 793-806. – volume: 51 start-page: 1546 year: 1998 end-page: 1554 article-title: Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria publication-title: Neurology – volume: 44 start-page: 1683 year: 1994 end-page: 1686 article-title: The risk of developing Creutzfeldt–Jakob disease in subjects with the PRNP gene codon 200 point mutation publication-title: Neurology – volume: 115 start-page: 601 year: 1991 end-page: 606 article-title: Clinical genetics and genetic counseling in Alzheimer disease publication-title: Ann Intern Med – volume: 128 start-page: 752 year: 2005 end-page: 772 article-title: Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation publication-title: Brain – volume: 122 start-page: 99 year: 2011 end-page: 110 article-title: The most common type of FTLD‐FUS (aFTLD‐U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene publication-title: Acta Neuropathol – volume: 65 start-page: 323 year: 2005 end-page: 325 article-title: Familial Alzheimer disease: Decreases in CSF Abeta42 levels precede cognitive decline publication-title: Neurology – volume: 71 start-page: 1220 year: 2008 end-page: 1226 article-title: Distinct genetic forms of frontotemporal dementia publication-title: Neurology – volume: 40 start-page: 2709 year: 2009 end-page: 2714 article-title: Prevalence and causes of early‐onset dementia in Japan: A population‐based study publication-title: Stroke – volume: 62 start-page: 1091 year: 2005 end-page: 1094 article-title: Spectrum of mutations in biopsy‐proven CADASIL: Implications for diagnostic strategies publication-title: Arch Neurol – volume: 67 start-page: 1473 year: 2010 end-page: 1484 article-title: Meta‐analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes publication-title: Arch Neurol – volume: 63 start-page: 168 year: 2006 end-page: 174 article-title: Role of genes and environments for explaining Alzheimer disease publication-title: Arch Gen Psychiatry – volume: 43 start-page: 436 year: 2011 end-page: 441 article-title: Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late‐onset Alzheimer's disease publication-title: Nat Genet – volume: 8 start-page: 48 year: 2008 article-title: Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland publication-title: BMC Neurol – volume: 71 start-page: 1235 year: 2008 end-page: 1239 article-title: Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration publication-title: Neurology – volume: 21 start-page: 281 year: 2006 end-page: 286 article-title: Frontotemporal dementia‐like phenotypes associated with presenilin‐1 mutations publication-title: Am J Alzheimers Dis Other Demen – volume: 47 start-page: 1113 year: 1996 end-page: 1124 article-title: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop publication-title: Neurology – volume: 65 start-page: 586 year: 2005 end-page: 590 article-title: Prevalence and patterns of cognitive impairment in sporadic ALS publication-title: Neurology – volume: 28 start-page: 416 year: 2007 article-title: Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia publication-title: Hum Mutat – volume: 131 start-page: 721 year: 2008 end-page: 731 article-title: Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: Comparison with patients with MAPT and no known mutations publication-title: Brain – volume: 17 start-page: 313 year: 2008 end-page: 322 article-title: CHMP2B C‐truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro publication-title: Hum Mol Genet – volume: 16 start-page: 171 year: 2008 end-page: 175 article-title: Low prevalence of APP duplications in Swedish and Finnish patients with early‐onset Alzheimer's disease publication-title: Eur J Hum Genet – volume: 15 start-page: 377 year: 2008 end-page: 385 article-title: Alzheimer disease‐like clinical phenotype in a family with FTDP‐17 caused by a MAPT R406W mutation publication-title: Eur J Neurol – volume: 55 start-page: 1577 year: 2000 end-page: 1578 article-title: Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation publication-title: Neurology – volume: 22 start-page: 294 year: 2007 end-page: 299 article-title: Progressive nonfluent aphasia associated with a new mutation V363I in tau gene publication-title: Am J Alzheimers Dis Other Demen – volume: 23 start-page: 347 year: 2009 end-page: 351 article-title: Frequency and causes of early‐onset dementia in a tertiary referral center in Athens publication-title: Alzheimer Dis Assoc Disord – volume: 78 start-page: 1411 year: 2007 end-page: 1413 article-title: De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementia publication-title: J Neurol Neurosurg Psychiatry – volume: 41 start-page: 1094 year: 2009 end-page: 1099 article-title: Genome‐wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease publication-title: Nat Genet – volume: 70 start-page: 698 year: 2011 end-page: 702 article-title: A second case of Gerstmann‐Straussler‐Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient publication-title: J Neuropathol Exp Neurol – volume: 249 start-page: 1567 year: 2002 end-page: 1582 article-title: Mutations of the prion protein gene phenotypic spectrum publication-title: J Neurol – volume: 135 start-page: 723 year: 2012 end-page: 735 article-title: The clinical and pathological phenotype of C9orf72 hexanucleotide repeat expansions publication-title: Brain – volume: 132 start-page: 1355 year: 2009 end-page: 1365 article-title: Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease publication-title: Brain – volume: 62 start-page: 925 year: 2005 end-page: 930 article-title: Frontotemporal lobar degeneration: Demographic characteristics of 353 patients publication-title: Arch Neurol – volume: 19 start-page: 1401 year: 2010 end-page: 1408 article-title: Early‐versus late‐onset Alzheimer's disease: More than age alone publication-title: J Alzheimers Dis – volume: 442 start-page: 916 year: 2006 end-page: 919 article-title: Mutations in progranulin cause tau‐negative frontotemporal dementia linked to chromosome 17 publication-title: Nature – volume: 366 start-page: 283 year: 2012 end-page: 284 article-title: Repeat expansion in C9ORF72 in Alzheimer's disease publication-title: N Engl J Med – volume: 38 start-page: 24 year: 2006 end-page: 26 article-title: APP locus duplication causes autosomal dominant early‐onset Alzheimer disease with cerebral amyloid angiopathy publication-title: Nat Genet – volume: 76 start-page: 1006 year: 2011 end-page: 1014 article-title: Classification of primary progressive aphasia and its variants publication-title: Neurology – volume: 131 start-page: 732 year: 2008 end-page: 746 article-title: Phenotype variability in progranulin mutation carriers: A clinical, neuropsychological, imaging and genetic study publication-title: Brain – volume: 135 start-page: 693 year: 2012 end-page: 708 article-title: Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations publication-title: Brain – volume: 393 start-page: 702 year: 1998 end-page: 705 article-title: Association of missense and 5′‐splice‐site mutations in tau with the inherited dementia FTDP‐17 publication-title: Nature – volume: 7 start-page: 263 year: 2011 end-page: 269 article-title: The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease publication-title: Alzheimers Dement – volume: 10 start-page: 162 year: 2011 end-page: 172 article-title: Behavioural‐variant frontotemporal dementia: Diagnosis, clinical staging, and management publication-title: Lancet Neurol – volume: 14 start-page: 141 year: 2005 end-page: 150 article-title: Emotional responses to APO E genotype disclosure for Alzheimer disease publication-title: J Genet Couns – volume: 36 start-page: 377 year: 2004 end-page: 381 article-title: Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin‐containing protein publication-title: Nat Genet – volume: 67 start-page: 161 year: 2010 end-page: 170 article-title: The spectrum of mutations in progranulin: A collaborative study screening 545 cases of neurodegeneration publication-title: Arch Neurol – volume: 16 start-page: 273 year: 2010 end-page: 279 article-title: Progranulin (GRN) in two siblings of a Latino family and in other patients with schizophrenia publication-title: Neurocase – volume: 59 start-page: 1759 year: 2002 end-page: 1763 article-title: Frequency of mutations in the presenilin and amyloid precursor protein genes in early‐onset Alzheimer disease in Spain publication-title: Arch Neurol – volume: 133 start-page: 3043 year: 2010 end-page: 3057 article-title: Prospective 10‐year surveillance of human prion diseases in Japan publication-title: Brain – volume: 18 start-page: 250 year: 2005 end-page: 255 article-title: Genetic risk assessment for adult children of people with Alzheimer's disease: The Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study publication-title: J Geriatr Psychiatry Neurol – volume: 73 start-page: 626 year: 2009 end-page: 632 article-title: Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His publication-title: Neurology – volume: 27 start-page: 6174 year: 2007 end-page: 6184 article-title: Amyloid deposition begins in the striatum of presenilin‐1 mutation carriers from two unrelated pedigrees publication-title: J Neurosci – volume: 57 start-page: 621 year: 2001 end-page: 625 article-title: Screening for PS1 mutations in a referral‐based series of AD cases: 21 novel mutations publication-title: Neurology – volume: 24 start-page: 1636 year: 2009 end-page: 1640 article-title: Clinical and genetic characteristics of non‐Asian dentatorubral‐pallidoluysian atrophy: A systematic review publication-title: Mov Disord – volume: 283 start-page: 29615 year: 2008 end-page: 29619 article-title: Amyloid precursor protein trafficking, processing, and function publication-title: J Biol Chem – volume: 218 start-page: 139 year: 1996 end-page: 141 article-title: Sequence analysis of presenilin‐1 gene mutation in Japanese Alzheimer's disease patients publication-title: Neurosci Lett – volume: 54 start-page: 573 year: 2003 end-page: 581 article-title: Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R publication-title: Ann Neurol – volume: 132 start-page: 568 year: 2009 end-page: 569 article-title: Progranulin plasma levels in the diagnosis of frontotemporal dementia publication-title: Brain – volume: 256 start-page: 184 year: 1992 end-page: 185 article-title: Alzheimer's disease: The amyloid cascade hypothesis publication-title: Science – volume: 65 start-page: 1817 year: 2005 end-page: 1819 article-title: Comparison of family histories in FTLD subtypes and related tauopathies publication-title: Neurology – volume: 72 start-page: 245 year: 2011 end-page: 256 article-title: Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p‐linked FTD and ALS publication-title: Neuron – volume: 68 start-page: 501 year: 2007 end-page: 508 article-title: Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study publication-title: Neurology – volume: 442 start-page: 920 year: 2006 end-page: 924 article-title: Null mutations in progranulin cause ubiquitin‐positive frontotemporal dementia linked to chromosome 17q21 publication-title: Nature – volume: 297 start-page: 353 year: 2002 end-page: 356 article-title: The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics publication-title: Science – volume: 34 start-page: 939 year: 1984 end-page: 944 article-title: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease publication-title: Neurology – volume: 257 start-page: 747 year: 2010 end-page: 753 article-title: Frequency of ubiquitin and FUS‐positive, TDP‐43‐negative frontotemporal lobar degeneration publication-title: J Neurol – volume: 49 start-page: 697 year: 2001 end-page: 705 article-title: Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy publication-title: Ann Neurol – volume: 71 start-page: 1496 year: 2008 end-page: 1499 article-title: Incidence of early‐onset dementias in Cambridgeshire, United Kingdom publication-title: Neurology – volume: 30 start-page: 14946 year: 2010 end-page: 14954 article-title: Amyloid‐independent mechanisms in Alzheimer's disease pathogenesis publication-title: J Neurosci – volume: 126 start-page: 2016 year: 2003 end-page: 2022 article-title: Frontotemporal dementia in The Netherlands: Patient characteristics and prevalence estimates from a population‐based study publication-title: Brain – volume: 13 start-page: 597 year: 2011 end-page: 605 article-title: Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors publication-title: Genet Med – volume: 59 start-page: 1134 year: 2002 end-page: 1138 article-title: Diagnostic strategies in CADASIL publication-title: Neurology – volume: 332 start-page: 478 year: 2011 end-page: 484 article-title: The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice publication-title: Science – volume: 66 start-page: 1537 year: 2009 end-page: 1544 article-title: High striatal amyloid beta‐peptide deposition across different autosomal Alzheimer disease mutation types publication-title: Arch Neurol – volume: 17 start-page: 298 year: 2004 end-page: 2301 article-title: The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy publication-title: Dement Geriatr Cogn Disord – volume: 15 start-page: 2988 year: 2006 end-page: 3001 article-title: Mutations in progranulin are a major cause of ubiquitin‐positive frontotemporal lobar degeneration publication-title: Hum Mol Genet – volume: 141B start-page: 944 year: 2006 end-page: 946 article-title: CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia publication-title: Am J Med Genet Part B – volume: 118 start-page: 115 year: 2009 end-page: 130 article-title: Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies publication-title: Acta Neuropathol – volume: 153B start-page: 1283 year: 2010 end-page: 1291 article-title: Somatic mosaicism in a case of apparently sporadic Creutzfeldt–Jakob disease carrying a de novo D178N mutation in the PRNP gene publication-title: Am J Med Genet Part B – volume: 69 start-page: 730 year: 2007 end-page: 738 article-title: Inherited prion disease with 5‐OPRI: Phenotype modification by repeat length and codon 129 publication-title: Neurology – volume: 1 start-page: 345 year: 1992 end-page: 347 article-title: A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N‐terminus of beta‐amyloid publication-title: Nat Genet – volume: 120 start-page: 33 year: 2010 end-page: 41 article-title: FUS pathology defines the majority of tau‐ and TDP‐43‐negative frontotemporal lobar degeneration publication-title: Acta Neuropathol – volume: 78 start-page: 1050 year: 2007 end-page: 1055 article-title: Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease publication-title: J Neurol Neurosurg Psychiatry – volume: 28 start-page: 846 year: 2007 end-page: 855 article-title: Progranulin null mutations in both sporadic and familial frontotemporal dementia publication-title: Hum Mutat – volume: 7 start-page: 43 year: 1998 end-page: 51 article-title: Estimation of the genetic contribution of presenilin‐1 and ‐2 mutations in a population‐based study of presenile Alzheimer disease publication-title: Hum Mol Genet – volume: 56 start-page: 1545 year: 2001 end-page: 1551 article-title: Presenilin‐1‐associated abnormalities in regional cerebral perfusion publication-title: Neurology – volume: 35 start-page: 2169 year: 2008 end-page: 2181 article-title: Regional analysis of FDG and PIB‐PET images in normal aging, mild cognitive impairment, and Alzheimer's disease publication-title: Eur J Nucl Med Mol Imaging – volume: 56 start-page: S21 year: 2001 end-page: S25 article-title: Missense and splice site mutations in tau associated with FTDP‐17: Multiple pathogenic mechanisms publication-title: Neurology – volume: 57 start-page: 139 year: 2005 end-page: 143 article-title: Pick bodies in a family with presenilin‐1 Alzheimer's disease publication-title: Ann Neurol – volume: 52 start-page: 355 year: 2002 end-page: 359 article-title: Spontaneous mutations in the prion protein gene causing transmissible spongiform encephalopathy publication-title: Ann Neurol – volume: 55 start-page: 617 year: 2004 end-page: 626 article-title: A novel presenilin 1 mutation associated with Pick's disease but not beta‐amyloid plaques publication-title: Ann Neurol – volume: 25 start-page: 96 year: 2011 end-page: 99 article-title: MAPT V363I variation in a sporadic case of frontotemporal dementia: Variable penetrant mutation or rare polymorphism? publication-title: Alzheimer Dis Assoc Disord – start-page: 209.e3 year: 2012 end-page: 209.e8 article-title: The chromosome 9 ALS and FTD locus is probably derived from a single founder publication-title: Neurobiol Aging – volume: 13 start-page: 1219 year: 2004 end-page: 1224 article-title: Somatic and germline mosaicism in sporadic early‐onset Alzheimer's disease publication-title: Hum Mol Genet – volume: 253 start-page: 139 year: 2006 end-page: 158 article-title: Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin‐1 gene publication-title: J Neurol – volume: 5 start-page: e9872 year: 2010 article-title: Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS) publication-title: PLoS ONE – volume: 60 start-page: 2020 year: 2003 article-title: Diagnostic strategies in CADASIL publication-title: Neurology – volume: 129 start-page: 2977 year: 2006 end-page: 2983 article-title: APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy publication-title: Brain – volume: 66 start-page: 110 year: 2000 end-page: 117 article-title: High prevalence of pathogenic mutations in patients with early‐onset dementia detected by sequence analyses of four different genes publication-title: Am J Hum Genet – volume: 133 start-page: 1143 year: 2010 end-page: 1154 article-title: Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2 publication-title: Brain – volume: 11 start-page: 219 year: 1995 end-page: 222 article-title: The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Alzheimer's Disease Collaborative Group publication-title: Nat Genet – volume: 287 start-page: 329 year: 2002 end-page: 336 article-title: Risk of dementia among white and African American relatives of patients with Alzheimer disease publication-title: JAMA – volume: 9 start-page: 197 year: 2008 end-page: 205 article-title: Progranulin genetic variations in frontotemporal lobar degeneration: Evidence for low mutation frequency in an Italian clinical series publication-title: Neurogenetics – volume: 74 start-page: 366 year: 2010 end-page: 371 article-title: Genetic contribution of FUS to frontotemporal lobar degeneration publication-title: Neurology – volume: 6 start-page: 475 year: 2004 end-page: 482 article-title: Pathological and clinical heterogeneity of presenilin 1 gene mutations publication-title: J Alzheimers Dis – volume: 122 start-page: 673 year: 2011 end-page: 690 article-title: Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 publication-title: Acta Neuropathol – volume: 287 start-page: 291 year: 2009 end-page: 293 article-title: Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease publication-title: J Neurol Sci – volume: 72 start-page: 257 year: 2011 end-page: 268 article-title: A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21‐linked ALS‐FTD publication-title: Neuron – volume: 197 start-page: 28 year: 2010 end-page: 35 article-title: Morbid risk for schizophrenia in first‐degree relatives of people with frontotemporal dementia publication-title: Br J Psychiatry – volume: 30 start-page: E974 year: 2009 end-page: E983 article-title: Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease publication-title: Hum Mutat – volume: 75 start-page: 807 year: 2010 end-page: 814 article-title: Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia publication-title: Neurology – volume: 41 start-page: 1088 year: 2009 end-page: 1093 article-title: Genome‐wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease publication-title: Nat Genet – volume: 129 start-page: 3081 year: 2006 end-page: 3090 article-title: The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene publication-title: Brain – volume: 72 start-page: 266 year: 2002 end-page: 269 article-title: A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances publication-title: J Neurol Neurosurg Psychiatry – volume: 17 start-page: 641 year: 2010 end-page: 648 article-title: EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias publication-title: Eur J Neurol – volume: 375 start-page: 754 year: 1995 end-page: 760 article-title: Cloning of a gene bearing missense mutations in early‐onset familial Alzheimer's disease publication-title: Nature – volume: 17 start-page: 63 year: 2007 end-page: 73 article-title: Hereditary frontotemporal dementia caused by Tau gene mutations publication-title: Brain Pathol – volume: 57 start-page: 72 year: 2000 end-page: 77 article-title: Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan publication-title: Arch Neurol – volume: 208 start-page: 264 year: 2007 end-page: 268 article-title: Early‐onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene publication-title: Exp Neurol – volume: 129 start-page: 2984 year: 2006 end-page: 2991 article-title: Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease publication-title: Brain – volume: 14 start-page: 1057 year: 2007 end-page: 1059 article-title: Dementia, delusions and seizures: Storage disease or genetic AD? publication-title: Eur J Neurol – volume: 134 start-page: 2582 year: 2011 end-page: 2594 article-title: Motor neuron dysfunction in frontotemporal dementia publication-title: Brain – volume: 132 start-page: 583 year: 2009 end-page: 591 article-title: Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members publication-title: Brain – volume: 58 start-page: 1803 year: 2001 end-page: 1809 article-title: Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease publication-title: Arch Neurol – volume: 134 start-page: 2456 year: 2011 end-page: 2477 article-title: Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia publication-title: Brain – volume: 71 start-page: 1489 year: 2008 end-page: 1495 article-title: Survival in Alzheimer disease: A multiethnic, population‐based study of incident cases publication-title: Neurology – volume: 58 start-page: 1828 year: 2001 end-page: 1831 article-title: Impact of DNA testing for early‐onset familial Alzheimer disease and frontotemporal dementia publication-title: Arch Neurol – volume: 33 start-page: 629 year: 2012 article-title: DLB and PDD: A role for mutations in dementia and Parkinson disease genes? publication-title: Neurobiol Aging – volume: 32 start-page: 1388 year: 2011 end-page: 1399 article-title: Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation publication-title: Neurobiol Aging – volume: 60 start-page: 235 year: 2003 end-page: 239 article-title: Early onset familial Alzheimer's disease: Mutation frequency in 31 families publication-title: Neurology – volume: 95 start-page: 7737 year: 1998 end-page: 7741 article-title: Mutation in the tau gene in familial multiple system tauopathy with presenile dementia publication-title: Proc Natl Acad Sci USA – volume: 134 start-page: 3030 year: 2011 end-page: 3043 article-title: Subtypes of progressive aphasia: Application of the international consensus criteria and validation using {beta}‐amyloid imaging publication-title: Brain – volume: 419 start-page: 1 year: 2007 end-page: 4 article-title: TDP‐43 gene analysis in frontotemporal lobar degeneration publication-title: Neurosci Lett – volume: 10 start-page: 207 year: 2008 end-page: 214 article-title: Incorporating ethnicity into genetic risk assessment for Alzheimer disease: The REVEAL study experience publication-title: Genet Med – volume: 46 start-page: 243 year: 1999 end-page: 248 article-title: Frequency of tau mutations in three series of non‐Alzheimer's degenerative dementia publication-title: Ann Neurol – volume: 61 start-page: 1136 year: 2003 end-page: 1137 article-title: Very early onset AD with a de novo mutation in the presenilin 1 gene (Met 233 Leu) publication-title: Neurology – volume: 103 start-page: 138 year: 2001 end-page: 143 article-title: Systematic genetic study of Alzheimer disease in Latin America: Mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia publication-title: Am J Med Genet – volume: 23 start-page: 269 year: 2010 end-page: 276 article-title: CADASIL publication-title: J Geriatr Psychiatry Neurol – volume: 60 start-page: 534 year: 2008 end-page: 542 article-title: Linking Abeta and tau in late‐onset Alzheimer's disease: A dual pathway hypothesis publication-title: Neuron – volume: 65 start-page: 664 year: 1999 end-page: 670 article-title: Early‐onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum publication-title: Am J Hum Genet – volume: 349 start-page: 704 year: 1991 end-page: 706 article-title: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease publication-title: Nature – volume: 18 start-page: 350 year: 2009 end-page: 356 article-title: A decade of genetic counseling in frontotemporal dementia affected families: Few counseling requests and much familial opposition to testing publication-title: J Genet Couns – volume: 256 start-page: 1620 year: 2009 end-page: 1628 article-title: Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies publication-title: J Neurol – volume: 129 start-page: 2297 year: 2006 end-page: 2317 article-title: Inherited prion disease with six octapeptide repeat insertional mutation—Molecular analysis of phenotypic heterogeneity publication-title: Brain – volume: 74 start-page: 1206 year: 2003 end-page: 1209 article-title: The prevalence and causes of dementia in people under the age of 65 years publication-title: J Neurol Neurosurg Psychiatry – volume: 67 start-page: 171 year: 2010 end-page: 177 article-title: Alzheimer disease‐like phenotype associated with the c.154delA mutation in progranulin publication-title: Arch Neurol – volume: 7 start-page: 208 year: 2011 end-page: 244 article-title: 2011 Alzheimer's disease facts and figures publication-title: Alzheimers Dement – volume: 68 start-page: 90 year: 2011 end-page: 93 article-title: Familial aggregation of dementia with Lewy bodies publication-title: Arch Neurol – volume: 73 start-page: 1451 year: 2009 end-page: 1456 article-title: The heritability and genetics of frontotemporal lobar degeneration publication-title: Neurology – volume: 283 start-page: 1744 year: 2008 end-page: 1753 article-title: Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin‐immunoreactive inclusions reduce progranulin production and secretion publication-title: J Biol Chem – volume: 58 start-page: 383 year: 2001 end-page: 387 article-title: Frequency of tau gene mutations in familial and sporadic cases of non‐Alzheimer dementia publication-title: Arch Neurol – volume: 24 start-page: 1843 year: 2009 end-page: 1847 article-title: TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea publication-title: Mov Disord – volume: 69 start-page: 712 year: 2011 end-page: 720 article-title: Familial prion disease with Alzheimer disease‐like tau pathology and clinical phenotype publication-title: Ann Neurol – volume: 22 start-page: 89 year: 2001 end-page: 107 article-title: Phenotypic correlations in FTDP‐17 publication-title: Neurobiol Aging – volume: 49 start-page: 263 year: 2001 end-page: 267 article-title: Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene publication-title: Ann Neurol – volume: 30 start-page: 1329 year: 2009 end-page: 1331 article-title: Neuronal inclusion protein TDP‐43 has no primary genetic role in FTD and ALS publication-title: Neurobiol Aging – volume: 22 start-page: 765 year: 2010 end-page: 769 article-title: FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis publication-title: J Alzheimers Dis – volume: 168 start-page: 413 year: 2001 end-page: 418 article-title: Clinic‐based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations publication-title: Exp Neurol – volume: 65 start-page: 506 year: 2008 end-page: 513 article-title: Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene publication-title: Arch Neurol – volume: 16 start-page: 903 year: 2011 end-page: 907 article-title: APOE and Alzheimer disease: A major gene with semi‐dominant inheritance publication-title: Mol Psychiatry – volume: 45 start-page: 706 year: 2011 end-page: 709 article-title: Genetic counseling for frontotemporal dementias publication-title: J Mol Neurosci – volume: 37 start-page: 806 year: 2005 end-page: 808 article-title: Mutations in the endosomal ESCRTIII‐complex subunit CHMP2B in frontotemporal dementia publication-title: Nat Genet – volume: 7 start-page: 1 year: 2011 end-page: 9 article-title: Cerebral amyloid angiopathy: A systematic review publication-title: J Clin Neurol – volume: 361 start-page: 245 year: 2009 end-page: 254 article-title: Disclosure of APOE genotype for risk of Alzheimer's disease publication-title: N Engl J Med – volume: 14 start-page: 13 year: 2002 end-page: 21 article-title: Familial frontotemporal dementia associated with a novel presenilin‐1 mutation publication-title: Dement Geriatr Cogn Disord – volume: 45 start-page: 663 year: 2011 end-page: 675 article-title: Making Connections: Pathology and Genetics Link Amyotrophic Lateral Sclerosis with Frontotemporal Lobe Dementia publication-title: J Mol Neurosci – volume: 11 start-page: e23 year: 2009 article-title: The molecular basis of frontotemporal dementia publication-title: Expert Rev Mol Med – volume: 72 start-page: 813 year: 2009 end-page: 820 article-title: Voxel‐based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN publication-title: Neurology – volume: 477 start-page: 211 year: 2011 end-page: 215 article-title: Mutations in UBQLN2 cause dominant X‐linked juvenile and adult‐onset ALS and ALS/dementia publication-title: Nature – volume: 63 start-page: 1307 year: 2006 end-page: 1311 article-title: Early‐onset Alzheimer disease in families with late‐onset Alzheimer disease: A potential important subtype of familial Alzheimer disease publication-title: Arch Neurol – volume: 9 start-page: 793 year: 2010 end-page: 806 article-title: The diagnosis of young‐onset dementia publication-title: Lancet Neurol – volume: 30 start-page: 157 year: 2009 end-page: 159 article-title: No association of TDP‐43 with sporadic frontotemporal dementia publication-title: Neurobiol Aging – volume: 68 start-page: 857 year: 2010 end-page: 864 article-title: Exome sequencing reveals VCP mutations as a cause of familial ALS publication-title: Neuron – volume: 22 start-page: 981 year: 2010 end-page: 984 article-title: Low serum progranulin predicts the presence of mutations: A prospective study publication-title: J Alzheimers Dis – volume: 252 start-page: 173 year: 2007 end-page: 176 article-title: The R269H mutation in presenilin‐1 presenting as late‐onset autosomal dominant Alzheimer's disease publication-title: J Neurol Sci – volume: 70 start-page: 1827 year: 2008 end-page: 1835 article-title: CSF biomarkers in frontotemporal lobar degeneration with known pathology publication-title: Neurology – volume: 61 start-page: 446 year: 2007 end-page: 453 article-title: Extreme cerebrospinal fluid amyloid beta levels identify family with late‐onset Alzheimer's disease presenilin 1 mutation publication-title: Ann Neurol – volume: 157 start-page: 633 year: 2001 end-page: 637 article-title: Genetic epidemiology of Creutzfeldt–Jakob disease in Europe publication-title: Rev Neurol (Paris) – volume: 68 start-page: 488 year: 2011 end-page: 497 article-title: Genetic and clinical features of progranulin‐associated frontotemporal lobar degeneration publication-title: Arch Neurol – volume: 58 start-page: 1615 year: 2002 end-page: 1621 article-title: The prevalence of frontotemporal dementia publication-title: Neurology – volume: 50 start-page: 1541 year: 1998 end-page: 1545 article-title: Familial aggregation in frontotemporal dementia publication-title: Neurology – volume: 11 start-page: 54 year: 2012 end-page: 65 article-title: A C9orf72 promoter repeat expansion in a Flanders‐Belgian cohort with disorders of the frontotemporal lobar degeneration‐amyotrophic lateral sclerosis spectrum: A gene identification study publication-title: Lancet Neurol – volume: 42 start-page: 793 year: 2005 end-page: 795 article-title: Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: An update publication-title: J Med Genet – ident: e_1_2_13_112_1 doi: 10.1212/01.wnl.0000171397.32851.bc – ident: e_1_2_13_24_1 doi: 10.1093/brain/awr195 – ident: e_1_2_13_15_1 doi: 10.1093/brain/awh356 – ident: e_1_2_13_30_1 doi: 10.1097/GIM.0b013e318164e4cf – ident: e_1_2_13_104_1 doi: 10.1093/brain/awl226 – ident: e_1_2_13_152_1 doi: 10.1192/bjp.bp.109.068981 – ident: e_1_2_13_37_1 doi: 10.1038/nature10353 – ident: e_1_2_13_101_1 doi: 10.1212/WNL.34.7.939 – ident: e_1_2_13_100_1 doi: 10.1212/WNL.47.5.1113 – ident: e_1_2_13_134_1 doi: 10.1212/WNL.58.11.1615 – ident: e_1_2_13_63_1 doi: 10.1038/ng.440 – ident: e_1_2_13_2_1 doi: 10.1111/j.1468-1331.2007.01664.x – ident: e_1_2_13_35_1 doi: 10.1002/ana.10267 – ident: e_1_2_13_5_1 – ident: e_1_2_13_155_1 doi: 10.1016/j.neurobiolaging.2007.05.022 – ident: e_1_2_13_27_1 doi: 10.1016/j.jns.2009.07.011 – ident: e_1_2_13_61_1 doi: 10.1126/science.1566067 – ident: e_1_2_13_103_1 doi: 10.1016/j.jalz.2011.03.005 – ident: e_1_2_13_180_1 doi: 10.1001/archneurol.2009.285 – ident: e_1_2_13_84_1 doi: 10.3233/JAD-2010-1337 – ident: e_1_2_13_53_1 doi: 10.1016/j.expneurol.2007.08.016 – ident: e_1_2_13_143_1 doi: 10.1177/0891988705281883 – ident: e_1_2_13_146_1 doi: 10.1212/WNL.0b013e3181bf997a – ident: e_1_2_13_158_1 doi: 10.1074/jbc.M705115200 – ident: e_1_2_13_185_1 doi: 10.1001/archneurol.2009.328 – ident: e_1_2_13_97_1 doi: 10.1093/brain/awl271 – volume: 60 start-page: 2020 year: 2003 ident: e_1_2_13_121_1 article-title: Diagnostic strategies in CADASIL publication-title: Neurology – ident: e_1_2_13_88_1 doi: 10.1038/ng.439 – ident: e_1_2_13_111_1 doi: 10.1080/13554790903456209 – ident: e_1_2_13_7_1 doi: 10.1097/WAD.0b013e3181eff860 – volume: 22 start-page: 765 year: 2010 ident: e_1_2_13_21_1 article-title: FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-100837 – ident: e_1_2_13_117_1 doi: 10.1212/WNL.51.6.1546 – ident: e_1_2_13_64_1 doi: 10.1136/jnnp.74.9.1206 – ident: e_1_2_13_85_1 doi: 10.1007/s00415-002-0896-9 – ident: e_1_2_13_125_1 doi: 10.1001/archneur.62.7.1091 – ident: e_1_2_13_102_1 doi: 10.1001/archneur.58.11.1803 – ident: e_1_2_13_79_1 doi: 10.1001/archneurol.2010.201 – ident: e_1_2_13_175_1 doi: 10.1093/hmg/ddm309 – ident: e_1_2_13_29_1 doi: 10.1001/archneurol.2011.53 – ident: e_1_2_13_3_1 – ident: e_1_2_13_123_1 doi: 10.1097/WAD.0b013e31819e6b28 – ident: e_1_2_13_89_1 doi: 10.1007/s00415-005-0019-5 – ident: e_1_2_13_170_1 doi: 10.1126/science.1199214 – ident: e_1_2_13_60_1 doi: 10.1002/ana.20366 – ident: e_1_2_13_22_1 doi: 10.1093/brain/awl212 – ident: e_1_2_13_140_1 doi: 10.1007/s10897-009-9222-3 – ident: e_1_2_13_70_1 doi: 10.1161/STROKEAHA.108.542308 – ident: e_1_2_13_58_1 doi: 10.1001/jama.287.3.329 – ident: e_1_2_13_153_1 doi: 10.3233/JAD-2010-101032 – ident: e_1_2_13_179_1 doi: 10.1111/j.1750-3639.2007.00052.x – ident: e_1_2_13_4_1 doi: 10.1016/j.jalz.2011.02.004 – ident: e_1_2_13_178_1 doi: 10.1212/WNL.0b013e3181ccc732 – ident: e_1_2_13_34_1 doi: 10.1038/nature05017 – ident: e_1_2_13_154_1 doi: 10.1016/j.neurobiolaging.2009.08.016 – ident: e_1_2_13_14_1 doi: 10.1038/sj.ejhg.5201966 – ident: e_1_2_13_127_1 doi: 10.1016/S1474-4422(10)70299-4 – ident: e_1_2_13_165_1 doi: 10.1093/brain/awr355 – ident: e_1_2_13_183_1 doi: 10.1212/01.wnl.0000343851.46573.67 – ident: e_1_2_13_18_1 doi: 10.7326/0003-4819-601 – ident: e_1_2_13_32_1 doi: 10.1371/journal.pone.0009872 – ident: e_1_2_13_161_1 doi: 10.1038/ng1609 – ident: e_1_2_13_86_1 doi: 10.1002/mds.22697 – ident: e_1_2_13_9_1 doi: 10.1038/nature05016 – ident: e_1_2_13_166_1 doi: 10.1073/pnas.95.13.7737 – ident: e_1_2_13_50_1 doi: 10.1016/j.neurobiolaging.2007.11.002 – ident: e_1_2_13_68_1 doi: 10.1212/WNL.56.suppl_4.S21 – ident: e_1_2_13_8_1 doi: 10.1002/1096-8628(20011001)103:2<138::AID-AJMG1529>3.0.CO;2-8 – ident: e_1_2_13_141_1 doi: 10.1212/01.wnl.0000172911.39167.b6 – ident: e_1_2_13_151_1 doi: 10.1038/ng1718 – ident: e_1_2_13_162_1 doi: 10.1093/brain/awl203 – ident: e_1_2_13_75_1 doi: 10.1002/ana.22264 – ident: e_1_2_13_150_1 doi: 10.1016/S1474-4422(10)70159-9 – ident: e_1_2_13_48_1 doi: 10.1038/mp.2011.52 – ident: e_1_2_13_167_1 doi: 10.1001/archneur.58.11.1828 – ident: e_1_2_13_11_1 doi: 10.1212/01.wnl.0000311445.21321.fc – ident: e_1_2_13_174_1 doi: 10.1002/humu.9484 – ident: e_1_2_13_23_1 doi: 10.1111/j.1468-1331.2010.02985.x – ident: e_1_2_13_177_1 doi: 10.1002/ana.10721 – ident: e_1_2_13_28_1 doi: 10.1212/WNL.44.9.1683 – ident: e_1_2_13_71_1 doi: 10.1093/brain/awp062 – ident: e_1_2_13_51_1 doi: 10.1016/S1474-4422(11)70261-7 – ident: e_1_2_13_54_1 doi: 10.1212/01.wnl.0000187068.92184.63 – ident: e_1_2_13_142_1 doi: 10.1002/ajmg.b.30410 – ident: e_1_2_13_77_1 doi: 10.1001/archneur.62.6.925 – ident: e_1_2_13_33_1 doi: 10.1093/hmg/7.1.43 – ident: e_1_2_13_107_1 doi: 10.1177/1533317506290448 – ident: e_1_2_13_118_1 doi: 10.1001/archneurol.2010.319 – ident: e_1_2_13_6_1 doi: 10.1002/ajmg.b.31099 – ident: e_1_2_13_173_1 doi: 10.1007/s00401-010-0698-6 – ident: e_1_2_13_38_1 doi: 10.1002/ana.20083 – ident: e_1_2_13_169_1 doi: 10.1016/S0304-3940(96)13138-4 – ident: e_1_2_13_105_1 doi: 10.1212/01.wnl.0000267642.41594.9d – ident: e_1_2_13_109_1 doi: 10.1212/01.wnl.0000334277.16896.fa – ident: e_1_2_13_93_1 doi: 10.1093/brain/awr216 – ident: e_1_2_13_110_1 doi: 10.1016/j.neurobiolaging.2011.08.005 – ident: e_1_2_13_145_1 doi: 10.1001/archneur.65.4.506 – ident: e_1_2_13_44_1 doi: 10.1093/brain/awn352 – ident: e_1_2_13_80_1 doi: 10.1186/1471-2377-8-48 – ident: e_1_2_13_128_1 doi: 10.1523/JNEUROSCI.4305-10.2010 – ident: e_1_2_13_56_1 doi: 10.1212/WNL.0b013e31821103e6 – ident: e_1_2_13_52_1 doi: 10.1038/349704a0 – ident: e_1_2_13_72_1 doi: 10.1097/NEN.0b013e3182270c54 – ident: e_1_2_13_129_1 doi: 10.1001/archneur.58.3.383 – ident: e_1_2_13_31_1 doi: 10.1038/ng1095-219 – ident: e_1_2_13_114_1 doi: 10.1177/1533317507302320 – ident: e_1_2_13_136_1 doi: 10.1136/jmg.2005.033456 – ident: e_1_2_13_55_1 doi: 10.1097/GIM.0b013e31821d69b8 – ident: e_1_2_13_90_1 doi: 10.1016/j.jns.2006.11.013 – ident: e_1_2_13_46_1 doi: 10.1093/hmg/ddl241 – ident: e_1_2_13_81_1 doi: 10.1002/ana.21099 – ident: e_1_2_13_95_1 doi: 10.1111/j.1468-1331.2008.02069.x – ident: e_1_2_13_39_1 doi: 10.1001/archneur.57.1.72 – ident: e_1_2_13_26_1 doi: 10.1136/jnnp.2007.121137 – ident: e_1_2_13_149_1 doi: 10.1093/brain/awg204 – ident: e_1_2_13_40_1 doi: 10.1212/01.wnl.0000244749.20056.d4 – ident: e_1_2_13_159_1 doi: 10.1038/375754a0 – ident: e_1_2_13_36_1 doi: 10.1016/j.neuron.2011.09.011 – ident: e_1_2_13_96_1 doi: 10.1001/archneur.59.11.1759 – ident: e_1_2_13_130_1 doi: 10.1212/01.WNL.0000086811.39675.79 – ident: e_1_2_13_87_1 doi: 10.1007/s00415-009-5163-x – ident: e_1_2_13_138_1 doi: 10.1016/j.neuron.2011.09.010 – ident: e_1_2_13_62_1 doi: 10.1126/science.1072994 – ident: e_1_2_13_19_1 doi: 10.1001/archneur.63.9.1307 – ident: e_1_2_13_92_1 doi: 10.1093/brain/awn012 – ident: e_1_2_13_98_1 doi: 10.1056/NEJMc1113592 – ident: e_1_2_13_144_1 doi: 10.1212/WNL.57.4.621 – ident: e_1_2_13_156_1 doi: 10.1212/01.wnl.0000319702.37497.72 – ident: e_1_2_13_59_1 doi: 10.1056/NEJMoa0809578 – ident: e_1_2_13_124_1 doi: 10.1002/1531-8249(20010201)49:2<263::AID-ANA50>3.0.CO;2-K – ident: e_1_2_13_181_1 doi: 10.1002/mds.22642 – ident: e_1_2_13_133_1 doi: 10.1093/brain/awr179 – ident: e_1_2_13_122_1 doi: 10.1159/000077158 – ident: e_1_2_13_83_1 doi: 10.1523/JNEUROSCI.0730-07.2007 – ident: e_1_2_13_160_1 doi: 10.1093/brain/awr353 – volume: 78 start-page: 1050 year: 2007 ident: e_1_2_13_20_1 article-title: Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.2006.113803 – ident: e_1_2_13_45_1 doi: 10.1086/302702 – ident: e_1_2_13_69_1 doi: 10.1038/31508 – ident: e_1_2_13_164_1 doi: 10.1007/s00401-011-0816-0 – ident: e_1_2_13_139_1 doi: 10.1007/s00401-009-0501-8 – ident: e_1_2_13_17_1 doi: 10.1002/humu.21100 – ident: e_1_2_13_78_1 doi: 10.1016/j.neuron.2010.11.036 – volume: 6 start-page: 475 year: 2004 ident: e_1_2_13_108_1 article-title: Pathological and clinical heterogeneity of presenilin 1 gene mutations publication-title: J Alzheimers Dis doi: 10.3233/JAD-2004-6503 – ident: e_1_2_13_137_1 doi: 10.1016/S0197-4580(00)00202-5 – ident: e_1_2_13_131_1 doi: 10.1007/s12031-011-9557-8 – ident: e_1_2_13_182_1 doi: 10.1038/ng1332 – ident: e_1_2_13_115_1 doi: 10.1007/s00401-011-0907-y – ident: e_1_2_13_57_1 doi: 10.1002/ana.1009 – ident: e_1_2_13_49_1 doi: 10.1212/01.wnl.0000325058.10218.fc – ident: e_1_2_13_94_1 doi: 10.1007/s00259-008-0833-y – ident: e_1_2_13_126_1 doi: 10.1093/brain/awm331 – ident: e_1_2_13_43_1 doi: 10.1007/s12031-011-9637-9 – ident: e_1_2_13_74_1 doi: 10.1093/brain/awq033 – ident: e_1_2_13_12_1 doi: 10.3988/jcn.2011.7.1.1 – ident: e_1_2_13_82_1 doi: 10.1001/archneurol.2010.113 – ident: e_1_2_13_172_1 doi: 10.1074/jbc.R800019200 – ident: e_1_2_13_176_1 doi: 10.1212/WNL.0b013e3181b389d9 – ident: e_1_2_13_67_1 doi: 10.1002/1531-8249(199908)46:2<243::AID-ANA14>3.0.CO;2-L – ident: e_1_2_13_91_1 doi: 10.1002/humu.20520 – ident: e_1_2_13_120_1 doi: 10.1093/brain/awq216 – ident: e_1_2_13_106_1 doi: 10.1016/j.neurobiolaging.2011.10.014 – ident: e_1_2_13_73_1 doi: 10.1212/01.WNL.0000042088.22694.E3 – ident: e_1_2_13_76_1 doi: 10.1212/WNL.56.11.1545 – ident: e_1_2_13_10_1 doi: 10.1093/hmg/ddh134 – ident: e_1_2_13_99_1 doi: 10.1212/WNL.59.8.1134 – ident: e_1_2_13_65_1 doi: 10.1212/01.wnl.0000334278.11022.42 – ident: e_1_2_13_148_1 doi: 10.1007/s10897-005-4063-1 – ident: e_1_2_13_13_1 doi: 10.1093/brain/awp009 – ident: e_1_2_13_16_1 doi: 10.1007/s10048-008-0127-3 – ident: e_1_2_13_25_1 doi: 10.1086/302553 – ident: e_1_2_13_42_1 doi: 10.1006/exnr.2000.7613 – ident: e_1_2_13_135_1 doi: 10.1212/WNL.55.10.1577 – ident: e_1_2_13_171_1 doi: 10.1159/000058328 – ident: e_1_2_13_132_1 doi: 10.1136/jnnp.72.2.266 – ident: e_1_2_13_47_1 doi: 10.1001/archpsyc.63.2.168 – ident: e_1_2_13_116_1 doi: 10.1038/ng.801 – ident: e_1_2_13_163_1 doi: 10.1016/j.neuron.2008.11.007 – ident: e_1_2_13_157_1 doi: 10.1007/s00415-009-5404-z – ident: e_1_2_13_113_1 doi: 10.1038/ng0892-345 – ident: e_1_2_13_184_1 doi: 10.1212/WNL.0b013e3181f07e0c – volume: 157 start-page: 633 year: 2001 ident: e_1_2_13_41_1 article-title: Genetic epidemiology of Creutzfeldt–Jakob disease in Europe publication-title: Rev Neurol (Paris) – ident: e_1_2_13_66_1 doi: 10.1177/0891988710383570 – ident: e_1_2_13_119_1 doi: 10.1017/S1462399409001136 – ident: e_1_2_13_147_1 doi: 10.1016/j.neulet.2007.03.044 – ident: e_1_2_13_168_1 doi: 10.1212/WNL.50.6.1541 |
| SSID | ssj0030577 |
| Score | 2.2128873 |
| SecondaryResourceType | review_article |
| Snippet | With increased frequency, clinical geneticists are asked for genetic advice on the heredity of dementia in families. Alzheimer's disease is in most cases a... |
| SourceID | proquest pubmed pascalfrancis crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 628 |
| SubjectTerms | Adult and adolescent clinical studies Age of Onset Algorithms Alzheimer's disease Biological and medical sciences Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Dementia - genetics early onset frontotemporal dementia General aspects. Genetic counseling Genetic Association Studies genetic counseling Genetic Predisposition to Disease genetic testing Genetics Humans Medical genetics Medical sciences Neurology Organic mental disorders. Neuropsychology Physicians Practice Guidelines as Topic Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry |
| Title | Genetics of dementia: Update and guidelines for the clinician |
| URI | https://api.istex.fr/ark:/67375/WNG-JP6RFDQN-M/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fajmg.b.32080 https://www.ncbi.nlm.nih.gov/pubmed/22815225 https://www.proquest.com/docview/1468009040 https://www.proquest.com/docview/1033451716 https://www.proquest.com/docview/1492622501 |
| Volume | 159B |
| WOSCitedRecordID | wos000308492000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1552-485X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0030577 issn: 1552-4841 databaseCode: DRFUL dateStart: 20030101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-xFhAvfIyvwKiMBLywbImdNAlvE6ND01qNiYq-Wf6Ip_GRTs2K4L_nzkkzKsEkxFuknJP4fOf8zj7_DuCFtqnLI65Ck0Q2TDLFQ61dFsY2Gyot8sgaT5l_lE0m-WxWHLcLbnQWpuGH6BbcyDP8fE0OrnS9e0kaqj5_O93RO4Ij5tmAPkfTTXrQ3z8ZTY9WczEas6-9SDxjYZIncZv6jk_Y_b392k-pT_r9QUmSqkY9uabAxZ8Q6Dqg9X-k0Z3_7ctduN1iUbbXGM89uFZWm3CjqU75cxNujtt99_tAFefotGPN5o5Zv6J4pt6w6TmtFzBVWXa6JL4syqFnCIMZwkrWHLpE83sA09G7j2_fh23hhdCkIsJw0onEcWeENoXDgEOpRNAGZGqUsTF3wuapEbZQES9KnBI0os4yjq1A-JbyRImH0KvmVfkYWJ6qKFJaDek5xC2IkTwG3a7QwwJfIgJ4vdK8NC0rORXH-CobPmUuSTdSS6-bAF520ucNG8df5F75QeyE1OILZbBlqfw0OZCHx8OT0f6HiRwHMFgb5a4BJ_ZmhE8BbK2GXbbeXVO4hD0ucP4L4Hl3G_2SNltUVc6XKBMJkaRERnSFjGdrRBAaB_CoManLD-A56pKnAWx7y7myv3LvcHzgr578m_hTuIUIkDdJc1vQu1gsy2dw3Xy_OKsXA9jIZvmg9alfmMggew |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED9By9cLH2NAYAwjAS8sW2InTcLbxOjGaKsxrWJvlj_iaXykU7si-O-5c9KMSjAJ8RYp5yQ-3zm_s8-_A3ihberyiKvQJJENk0zxUGuXhbHNekqLPLLGU-YPstEoPz4uDpo6p3QWpuaHaBfcyDP8fE0OTgvSWxesoerzt5NNvSk4gp6r0E3QktIOdHcO--PBYjJGa_bFF4loLEzyJG5y3_EJW7-3X_ordUnBPyhLUs1QUa6ucPEnCLqMaP0vqX_nvztzF243aJRt1-ZzD66U1Qpcr-tT_lyBG8Nm5_0-UM05Ou84YxPHrF9TPFVv2PiMVgyYqiw7mRNjFmXRMwTCDIElq49dogGuwrj_7ujtXtiUXghNKiIMKJ1IHHdGaFM4DDmUSgRtQaZGGRtzJ2yeGmELFfGixElBI-4s49jiECAgSJR4AJ1qUpWPgOWpiiKlVY-eQ-yCGMtj2O0K3SvwJSKA1wvVS9PwklN5jK-yZlTmknQjtfS6CeBlK31W83H8Re6VH8VWSE2_UA5blspPo125f9A77O98HMlhAOtLw9w24MTfjAAqgLXFuMvGv2cUMGGPC5wBA3je3kbPpO0WVZWTOcpEQiQp0RFdIuP5GhGGxgE8rG3q4gN4jrrkaQAb3nQu7a_c3h_u-qvH_yb-DG7uHQ0HcvB-9OEJ3EI8yOsUujXonE_n5VO4Zr6fn86m641r_QIOuCOD |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED_BChMvfIyvwBhGAl4gW2LH-eBtonQw2qhMVOzNsuN4Gh9p1a4I_nvukjSjEkxCvEXKOYnPd87v7PPvAJ4aK10acO0XUWD9KNHcN8YlfmiTWBuRBraoKfOHSZ6nx8fZuK1zSmdhGn6IbsGNPKOer8nBy5l1e-esofrzt5Ndsys4gp7L0ItkFqNn9vpHg8lwNRmjNdfFF4lozI_SKGxz3_EJe7-3X_sr9UjBPyhLUi9QUa6pcPEnCLqOaOtf0uDGf3fmJlxv0Sjbb8znFlwqqy242tSn_LkFm6N25_02UM05Ou-4YFPHbL2meKpfscmMVgyYriw7WRJjFmXRMwTCDIEla45dogHegcngzcfXb_229IJfSBFgQOlE5LgrhCkyhyGH1pGgLUhZ6MKG3AmbykLYTAc8K3FSMIg7yzC0AgGc5JEWd2GjmlblfWCp1EGgjY7pOcQuiLE8ht0uM3GGLxEevFipXhUtLzmVx_iqGkZlrkg3yqhaNx4866RnDR_HX-Se16PYCen5F8phS6T6lB-ow3F8NOh_yNXIg521Ye4acOJvRgDlwfZq3FXr3wsKmLDHGc6AHjzpbqNn0naLrsrpEmUCISJJdEQXyNR8jQhDQw_uNTZ1_gE8RV1y6cHL2nQu7K_aPxwd1FcP_k38MWyO-wM1fJe_fwjXEA7yJoNuGzbO5svyEVwpvp-dLuY7rWf9AmYCIv4 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetics+of+dementia%3A+update+and+guidelines+for+the+clinician&rft.jtitle=American+journal+of+medical+genetics.+Part+B%2C+Neuropsychiatric+genetics&rft.au=Cohn-Hokke%2C+Petra+E&rft.au=Elting%2C+Mariet+W&rft.au=Pijnenburg%2C+Yolande+A+L&rft.au=van+Swieten%2C+John+C&rft.date=2012-09-01&rft.eissn=1552-485X&rft.volume=159B&rft.issue=6&rft.spage=628&rft_id=info:doi/10.1002%2Fajmg.b.32080&rft_id=info%3Apmid%2F22815225&rft.externalDocID=22815225 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-4841&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-4841&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-4841&client=summon |